-
1
-
-
84855792427
-
Cancer statistics, 2012
-
Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10-29.
-
(2012)
CA: A Cancer Journal for Clinicians
, vol.62
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
3
-
-
1842612441
-
Molecular determinants of resistance to antiandrogen therapy
-
DOI 10.1038/nm972
-
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004). Molecular determinants of resistance to antiandrogen therapy. Nature Medicine, 10, 33-39. (Pubitemid 38524696)
-
(2004)
Nature Medicine
, vol.10
, Issue.1
, pp. 33-39
-
-
Chen, C.D.1
Welsbie, D.S.2
Tran, C.3
Baek, S.H.4
Chen, R.5
Vessella, R.6
Rosenfeld, M.G.7
Sawyers, C.L.8
-
4
-
-
48549089747
-
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
-
Dehm, S. M., Schmidt, L. J., Heemers, H. V., Vessella, R. L., & Tindall, D. J. (2008). Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Research, 68, 5469-5477.
-
(2008)
Cancer Research
, vol.68
, pp. 5469-5477
-
-
Dehm, S.M.1
Schmidt, L.J.2
Heemers, H.V.3
Vessella, R.L.4
Tindall, D.J.5
-
5
-
-
34250331066
-
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer
-
DOI 10.1158/0008-5472.CAN-06-3332
-
Mostaghel, E. A., Page, S. T., Lin, D. W., Fazli, L., Coleman, I. M., True, L. D., Knudsen, B., Hess, D. L., Nelson, C. C., Matsumoto, A. M., Bremner, W. J., Gleave, M. E., & Nelson, P. S. (2007). Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Research, 67, 5033-5041. (Pubitemid 46910214)
-
(2007)
Cancer Research
, vol.67
, Issue.10
, pp. 5033-5041
-
-
Mostaghel, E.A.1
Page, S.T.2
Lin, D.W.3
Fazli, L.4
Coleman, I.M.5
True, L.D.6
Knudsen, B.7
Hess, D.L.8
Nelson, C.C.9
Matsumoto, A.M.10
Bremner, W.J.11
Gleave, M.E.12
Nelson, P.S.13
-
6
-
-
10844235652
-
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
-
DOI 10.1158/0008-5472.CAN-04-2442
-
Shah, R. B., Mehra, R., Chinnaiyan, A. M., Shen, R., Ghosh, D., Zhou, M., Macvicar, G. R., Varambally, S., Harwood, J., Bismar, T. A., Kim, R., Rubin, M. A., & Pienta, K. J. (2004). Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons froma rapid autopsy program. Cancer Research, 64, 9209-9216. (Pubitemid 39665537)
-
(2004)
Cancer Research
, vol.64
, Issue.24
, pp. 9209-9216
-
-
Shah, R.B.1
Mehra, R.2
Chinnaiyan, A.M.3
Shen, R.4
Ghosh, D.5
Zhou, M.6
MacVicar, G.R.7
Varambally, S.8
Harwood, J.9
Bismar, T.A.10
Kim, R.11
Rubin, M.A.12
Pienta, K.J.13
-
7
-
-
0034095472
-
Rapid ('warm') autopsy study for procurement of metastatic prostate cancer
-
Rubin, M. A., Putzi, M., Mucci, N., Smith, D. C., Wojno, K., Korenchuk, S., & Pienta, K. J. (2000). Rapid ("warm") autopsy study for procurement ofmetastatic prostate cancer. Clinical Cancer Research, 6, 1038-1045. (Pubitemid 30159365)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.3
, pp. 1038-1045
-
-
Rubin, M.A.1
Putzi, M.2
Mucci, N.3
Smith, D.C.4
Wojno, K.5
Korenchuk, S.6
Pienta, K.J.7
-
8
-
-
67349257845
-
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
-
Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., Chen, L., Ewing, C. M., Eisenberger, M. A., Carducci, M. A., Nelson, W. G., Yegnasubramanian, S., Luo, J., Wang, Y., Xu, J., Isaacs, W. B., Visakorpi, T., & Bova, G. S. (2009). Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nature Medicine, 15, 559-565.
-
(2009)
Nature Medicine
, vol.15
, pp. 559-565
-
-
Liu, W.1
Laitinen, S.2
Khan, S.3
Vihinen, M.4
Kowalski, J.5
Yu, G.6
Chen, L.7
Ewing, C.M.8
Eisenberger, M.A.9
Carducci, M.A.10
Nelson, W.G.11
Yegnasubramanian, S.12
Luo, J.13
Wang, Y.14
Xu, J.15
Isaacs, W.B.16
Visakorpi, T.17
Bova, G.S.18
-
9
-
-
84872732113
-
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases
-
Aryee, M. J., Liu, W., Engelmann, J. C., Nuhn, P., Gurel, M., Haffner, M. C., Esopi, D., Irizarry, R. A., Getzenberg, R. H., Nelson, W. G., Luo, J., Xu, J., Isaacs, W. B., Bova, G. S., & Yegnasubramanian, S. (2013). "DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases,". Science Translational Medicine, 5, 169ra10.
-
(2013)
Science Translational Medicine
, vol.5
-
-
Aryee, M.J.1
Liu, W.2
Engelmann, J.C.3
Nuhn, P.4
Gurel, M.5
Haffner, M.C.6
Esopi, D.7
Irizarry, R.A.8
Getzenberg, R.H.9
Nelson, W.G.10
Luo, J.11
Xu, J.12
Isaacs, W.B.13
Bova, G.S.14
Yegnasubramanian, S.15
-
10
-
-
43049165453
-
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
-
DOI 10.1016/j.cell.2008.03.027, PII S0092867408004443
-
Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., Campbell, L. L., Polyak, K., Brisken, C., Yang, J., & Weinberg, R. A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-715. (Pubitemid 351636299)
-
(2008)
Cell
, vol.133
, Issue.4
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.-J.3
Eaton, E.Ng.4
Ayyanan, A.5
Zhou, A.Y.6
Brooks, M.7
Reinhard, F.8
Zhang, C.C.9
Shipitsin, M.10
Campbell, L.L.11
Polyak, K.12
Brisken, C.13
Yang, J.14
Weinberg, R.A.15
-
11
-
-
33244463813
-
Complex networks orchestrate epithelial-mesenchymal transitions
-
Thiery, J. P., & Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews Molecular Cell Biology, 7, 131-142.
-
(2006)
Nature Reviews Molecular Cell Biology
, vol.7
, pp. 131-142
-
-
Thiery, J.P.1
Sleeman, J.P.2
-
12
-
-
47549102418
-
Epithelial mesenchymal transition traits in human breast cancer cell lines
-
Blick, T., Widodo, E., Hugo, H., Waltham, M., Lenburg, M. E., Neve, R. M., & Thompson, E. W. (2008). Epithelial mesenchymal transition traits in human breast cancer cell lines. Clinical & Experimental Metastasis, 25, 629-642.
-
(2008)
Clinical & Experimental Metastasis
, vol.25
, pp. 629-642
-
-
Blick, T.1
Widodo, E.2
Hugo, H.3
Waltham, M.4
Lenburg, M.E.5
Neve, R.M.6
Thompson, E.W.7
-
13
-
-
34848826864
-
Epithelial - Mesenchymal and mesenchymal - Epithelial transitions in carcinoma progression
-
DOI 10.1002/jcp.21223
-
Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., & Thompson, E. W. (2007). Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. Journal of Cellular Physiology, 213, 374-383. (Pubitemid 47509716)
-
(2007)
Journal of Cellular Physiology
, vol.213
, Issue.2
, pp. 374-383
-
-
Hugo, H.1
Ackland, M.L.2
Blick, T.3
Lawrence, M.G.4
Clements, J.A.5
Williams, E.D.6
Thompson, E.W.7
-
14
-
-
77956280130
-
Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness
-
Giannoni, E., Bianchini, F., Masieri, L., Serni, S., Torre, E., Calorini, L., & Chiarugi, P. (2010). Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Research, 70, 6945-6956.
-
(2010)
Cancer Research
, vol.70
, pp. 6945-6956
-
-
Giannoni, E.1
Bianchini, F.2
Masieri, L.3
Serni, S.4
Torre, E.5
Calorini, L.6
Chiarugi, P.7
-
15
-
-
80051988763
-
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers
-
Armstrong, A. J., Marengo, M. S., Oltean, S., Kemeny, G., Bitting, R. L., Turnbull, J. D., Herold, C. I., Marcom, P. K., George, D. J., & Garcia-Blanco, M. A. (2011). Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Molecular Cancer Research, 9, 997-1007.
-
(2011)
Molecular Cancer Research
, vol.9
, pp. 997-1007
-
-
Armstrong, A.J.1
Marengo, M.S.2
Oltean, S.3
Kemeny, G.4
Bitting, R.L.5
Turnbull, J.D.6
Herold, C.I.7
Marcom, P.K.8
George, D.J.9
Garcia-Blanco, M.A.10
-
16
-
-
77952308856
-
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
-
Zhu, M. L., & Kyprianou, N. (2010). Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. FASEB Journal, 24, 769-777.
-
(2010)
FASEB Journal
, vol.24
, pp. 769-777
-
-
Zhu, M.L.1
Kyprianou, N.2
-
17
-
-
44049100934
-
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
-
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M. F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., Wong, H., Rosen, J., & Chang, J. C. (2008). Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. Journal of the National Cancer Institute, 100, 672-679.
-
(2008)
Journal of the National Cancer Institute
, vol.100
, pp. 672-679
-
-
Li, X.1
Lewis, M.T.2
Huang, J.3
Gutierrez, C.4
Osborne, C.K.5
Wu, M.F.6
Hilsenbeck, S.G.7
Pavlick, A.8
Zhang, X.9
Chamness, G.C.10
Wong, H.11
Rosen, J.12
Chang, J.C.13
-
18
-
-
12944288172
-
Prevalence of CD44+/CD24-/low cells in breast cancer
-
may not be associated with clinical outcome but may favor distant metastasis.
-
Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. (2005). Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clinical Cancer Research, 11, 1154-1159.
-
(2005)
Clinical Cancer Research
, vol.11
, pp. 1154-1159
-
-
Abraham, B.K.1
Fritz, P.2
McClellan, M.3
Hauptvogel, P.4
Athelogou, M.5
Brauch, H.6
-
19
-
-
35848955428
-
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
-
DOI 10.1016/j.stem.2007.08.014, PII S1934590907001336
-
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M. S., & Dontu, G. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1, 555-567. (Pubitemid 350056407)
-
(2007)
Cell Stem Cell
, vol.1
, Issue.5
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
Monville, F.4
Dutcher, J.5
Brown, M.6
Jacquemier, J.7
Viens, P.8
Kleer, C.G.9
Liu, S.10
Schott, A.11
Hayes, D.12
Birnbaum, D.13
Wicha, M.S.14
Dontu, G.15
-
20
-
-
23744443516
-
Prognostic significance of plasma chromogranin A levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study
-
DOI 10.1016/j.urology.2005.03.040, PII S0090429505003511
-
Taplin, M. E., George, D. J., Halabi, S., Sanford, B., Febbo, P. G., Hennessy, K. T., Mihos, C. G., Vogelzang, N. J., Small, E. J., & Kantoff, P. W. (2005). Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study. Urology, 66, 386-391. (Pubitemid 41138103)
-
(2005)
Urology
, vol.66
, Issue.2
, pp. 386-391
-
-
Taplin, M.-E.1
George, D.J.2
Halabi, S.3
Sanford, B.4
Febbo, P.G.5
Hennessy, K.T.6
Mihos, C.G.7
Vogelzang, N.J.8
Small, E.J.9
Kantoff, P.W.10
-
21
-
-
84879853237
-
Platinum-based chemotherapy for variant castrate-resistant prostate cancer
-
Aparicio, A. M., Harzstark, A., Corn, P. G., Wen, S., Araujo, J., Tu, S. M., Pagliaro, L., Kim, J., Millikan, R. E., Ryan, C. J., Tannir, N. M., Zurita, A., Mathew, P., Arap, W., Troncoso, P., Thall, P., & Logothetis, C. J. (2013). Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res, 19, 3621-3630.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 3621-3630
-
-
Aparicio, A.M.1
Harzstark, A.2
Corn, P.G.3
Wen, S.4
Araujo, J.5
Tu, S.M.6
Pagliaro, L.7
Kim, J.8
Millikan, R.E.9
Ryan, C.J.10
Tannir, N.M.11
Zurita, A.12
Mathew, P.13
Arap, W.14
Troncoso, P.15
Thall, P.16
Logothetis, C.J.17
-
22
-
-
79953118839
-
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
-
Sequist, L. V., Waltman, B. A., Dias-Santagata, D., Digumarthy, S., Turke, A. B., Fidias, P., Bergethon, K., Shaw, A. T., Gettinger, S., Cosper, A. K., Akhavanfard, S., Heist, R. S., Temel, J., Christensen, J. G., Wain, J. C., Lynch, T. J., Vernovsky, K., Mark, E. J., Lanuti, M., Iafrate, A. J., Mino-Kenudson, M., & Engelman, J. A. (2011). Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Science Translational Medicine, 3, 75ra26.
-
(2011)
Science Translational Medicine
, vol.3
-
-
Sequist, L.V.1
Waltman, B.A.2
Dias-Santagata, D.3
Digumarthy, S.4
Turke, A.B.5
Fidias, P.6
Bergethon, K.7
Shaw, A.T.8
Gettinger, S.9
Cosper, A.K.10
Akhavanfard, S.11
Heist, R.S.12
Temel, J.13
Christensen, J.G.14
Wain, J.C.15
Lynch, T.J.16
Vernovsky, K.17
Mark, E.J.18
Lanuti, M.19
Iafrate, A.J.20
Mino-Kenudson, M.21
Engelman, J.A.22
more..
-
23
-
-
2342573663
-
Prostate Carcinoma with Squamous Differentiation: An Analysis of 33 Cases
-
Parwani, A. V., Kronz, J. D., Genega, E. M., Gaudin, P., Chang, S., & Epstein, J. I. (2004). Prostate carcinoma with squamous differentiation: An analysis of 33 cases. The American Journal of Surgical Pathology, 28, 651-657. (Pubitemid 38579569)
-
(2004)
American Journal of Surgical Pathology
, vol.28
, Issue.5
, pp. 651-657
-
-
Parwani, A.V.1
Kronz, J.D.2
Genega, E.M.3
Gaudin, P.4
Chang, S.5
Epstein, J.I.6
-
24
-
-
0035167146
-
Neuroendocrine differentiation in prostatic carcinoma: An update on recent developments
-
di Sant'Agnese, P. A. (2001). Neuroendocrine differentiation in prostatic carcinoma: An update on recent developments. Annals of Oncology, 12(Suppl 2), S135-S140.
-
(2001)
Annals of Oncology
, vol.12
, Issue.SUPPL. 2
-
-
Di Sant'Agnese, P.A.1
-
25
-
-
20144388470
-
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease
-
DOI 10.1677/erc.1.00876
-
Berruti, A., Mosca, A., Tucci, M., Terrone, C., Torta, M., Tarabuzzi, R., Russo, L., Cracco, C., Bollito, E., Scarpa, R. M., Angeli, A., & Dogliotti, L. (2005). Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormonerefractory disease. Endocrine-Related Cancer, 12, 109-117. (Pubitemid 40477092)
-
(2005)
Endocrine-Related Cancer
, vol.12
, Issue.1
, pp. 109-117
-
-
Berruti, A.1
Mosca, A.2
Tucci, M.3
Terrone, C.4
Torta, M.5
Tarabuzzi, R.6
Russo, L.7
Cracco, C.8
Bollito, E.9
Scarpa, R.M.10
Angeli, A.11
Dogliotti, L.12
-
26
-
-
37549037864
-
Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases
-
Wang, W., & Epstein, J. I. (2008). Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. The American Journal of Surgical Pathology, 32, 65-71.
-
(2008)
The American Journal of Surgical Pathology
, vol.32
, pp. 65-71
-
-
Wang, W.1
Epstein, J.I.2
-
28
-
-
84860168795
-
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
-
Beltran, H., Rickman, D. S., Park, K., Chae, S. S., Sboner, A., MacDonald, T. Y., Wang, Y., Sheikh, K. L., Terry, S., Tagawa, S. T., Dhir, R., Nelson, J. B., de la Taille, A., Allory, Y., Gerstein, M. B., Perner, S., Pienta, K. J., Chinnaiyan, A. M., Collins, C. C., Gleave, M. E., Demichelis, F., Nanus, D. M., & Rubin, M. A. (2011). Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discovery, 1, 487-495.
-
(2011)
Cancer Discovery
, vol.1
, pp. 487-495
-
-
Beltran, H.1
Rickman, D.S.2
Park, K.3
Chae, S.S.4
Sboner, A.5
MacDonald, T.Y.6
Wang, Y.7
Sheikh, K.L.8
Terry, S.9
Tagawa, S.T.10
Dhir, R.11
Nelson, J.B.12
De La Taille, A.13
Allory, Y.14
Gerstein, M.B.15
Perner, S.16
Pienta, K.J.17
Chinnaiyan, A.M.18
Collins, C.C.19
Gleave, M.E.20
Demichelis, F.21
Nanus, D.M.22
Rubin, M.A.23
more..
-
29
-
-
84872356711
-
EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts
-
Giannoni, E., Taddei, M. L., Parri, M., Bianchini, F., Santosuosso, M., Grifantini, R., Fibbi, G., Mazzanti, B., Calorini, L., & Chiarugi, P. (2013). EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts. Journal Molecules Medical (Berl), 91, 103-115.
-
(2013)
Journal Molecules Medical (Berl)
, vol.91
, pp. 103-115
-
-
Giannoni, E.1
Taddei, M.L.2
Parri, M.3
Bianchini, F.4
Santosuosso, M.5
Grifantini, R.6
Fibbi, G.7
Mazzanti, B.8
Calorini, L.9
Chiarugi, P.10
-
30
-
-
0033153362
-
Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
-
DOI 10.1002/(SICI)1097-0045(19990601)39:4<246::AID
-
Koeneman, K. S., Yeung, F., & Chung, L. W. (1999). Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate, 39, 246-261. (Pubitemid 29244499)
-
(1999)
Prostate
, vol.39
, Issue.4
, pp. 246-261
-
-
Koeneman, K.S.1
Yeung, F.2
Chung, L.W.K.3
-
31
-
-
79953299688
-
beta2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bonemetastasis in human cancer cells
-
Josson, S., Nomura, T., Lin, J. T., Huang, W. C., Wu, D., Zhau, H. E., Zayzafoon, M., Weizmann, M. N., Gururajan, M., & Chung, L. W. (2011). beta2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bonemetastasis in human cancer cells. Cancer Research, 71, 2600-2610.
-
(2011)
Cancer Research
, vol.71
, pp. 2600-2610
-
-
Josson, S.1
Nomura, T.2
Lin, J.T.3
Huang, W.C.4
Wu, D.5
Zhau, H.E.6
Zayzafoon, M.7
Weizmann, M.N.8
Gururajan, M.9
Chung, L.W.10
-
32
-
-
79954619522
-
Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells
-
Zhau, H. E., He, H., Wang, C. Y., Zayzafoon, M., Morrissey, C., Vessella, R. L., Marshall, F. F., Chung, L. W., & Wang, R. (2011). Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells. Clinical Cancer Research, 17, 2159-2169.
-
(2011)
Clinical Cancer Research
, vol.17
, pp. 2159-2169
-
-
Zhau, H.E.1
He, H.2
Wang, C.Y.3
Zayzafoon, M.4
Morrissey, C.5
Vessella, R.L.6
Marshall, F.F.7
Chung, L.W.8
Wang, R.9
-
33
-
-
0035878944
-
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway
-
Yang, J., Fizazi, K., Peleg, S., Sikes, C. R., Raymond, A. K., Jamal, N., Hu, M., Olive, M., Martinez, L. A., Wood, C. G., Logothetis, C. J., Karsenty, G., & Navone, N. M. (2001). Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Cancer Research, 61, 5652-5659. (Pubitemid 32694953)
-
(2001)
Cancer Research
, vol.61
, Issue.14
, pp. 5652-5659
-
-
Yang, J.1
Fizazi, K.2
Peleg, S.3
Sikes, C.R.4
Raymond, A.K.5
Jamal, N.6
Hu, M.7
Olive, M.8
Martinez, L.A.9
Wood, C.G.10
Logothetis, C.J.11
Karsenty, G.12
Navone, N.M.13
-
34
-
-
0030451767
-
Androgen-repressed phenotype in human prostate cancer
-
DOI 10.1073/pnas.93.26.15152
-
Zhau, H. Y., Chang, S. M., Chen, B. Q., Wang, Y., Zhang, H., Kao, C., Sang, Q. A., Pathak, S. J., & Chung, L. W. (1996). Androgen-repressed phenotype in human prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 93, 15152-15157. (Pubitemid 27009568)
-
(1996)
Proceedings of the National Academy of Sciences of the United States of America
, vol.93
, Issue.26
, pp. 15152-15157
-
-
Zhau, H.Y.E.1
Chang, S.-M.2
Chen, B.-Q.3
Wang, Y.4
Zhang, H.5
Kao, C.6
Sang, Q.A.7
Pathak, S.J.8
Chung, L.W.K.9
-
35
-
-
54449098848
-
Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation
-
Ke, X. S., Qu, Y., Goldfinger, N., Rostad, K., Hovland, R., Akslen, L. A., Rotter, V., Oyan, A. M., & Kalland, K. H. (2008). Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLoS One, 3, e3368.
-
(2008)
PLoS One
, vol.3
-
-
Ke, X.S.1
Qu, Y.2
Goldfinger, N.3
Rostad, K.4
Hovland, R.5
Akslen, L.A.6
Rotter, V.7
Oyan, A.M.8
Kalland, K.H.9
-
36
-
-
79952366631
-
Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line
-
Marian, C. O., Yang, L., Zou, Y. S., Gore, C., Pong, R. C., Shay, J. W., Kabbani, W., Hsieh, J. T., & Raj, G. V. (2011). Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line. Prostate, 71, 626-636.
-
(2011)
Prostate
, vol.71
, pp. 626-636
-
-
Marian, C.O.1
Yang, L.2
Zou, Y.S.3
Gore, C.4
Pong, R.C.5
Shay, J.W.6
Kabbani, W.7
Hsieh, J.T.8
Raj, G.V.9
-
37
-
-
84860578009
-
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
-
Celia-Terrassa, T., Meca-Cortes, O., Mateo, F., de Paz, A. M., Rubio, N., Arnal-Estape, A., Ell, B. J., Bermudo, R., Diaz, A., Guerra-Rebollo, M., Lozano, J. J., Estaras, C., Ulloa, C., Alvarez-Simon, D., Mila, J., Vilella, R., Paciucci, R., Martinez-Balbas, M., de Herreros, A. G., Gomis, R. R., Kang, Y., Blanco, J., Fernandez, P. L., & Thomson, T. M. (2012). Epithelial- mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. The Journal of Clinical Investigation, 122, 1849-1868.
-
(2012)
The Journal of Clinical Investigation
, vol.122
, pp. 1849-1868
-
-
Celia-Terrassa, T.1
Meca-Cortes, O.2
Mateo, F.3
De Paz, A.M.4
Rubio, N.5
Arnal-Estape, A.6
Ell, B.J.7
Bermudo, R.8
Diaz, A.9
Guerra-Rebollo, M.10
Lozano, J.J.11
Estaras, C.12
Ulloa, C.13
Alvarez-Simon, D.14
Mila, J.15
Vilella, R.16
Paciucci, R.17
Martinez-Balbas, M.18
De Herreros, A.G.19
Gomis, R.R.20
Kang, Y.21
Blanco, J.22
Fernandez, P.L.23
Thomson, T.M.24
more..
-
38
-
-
24944450362
-
The transcriptional repressor Snail promotes mammary tumor recurrence
-
DOI 10.1016/j.ccr.2005.07.009, PII S153561080500231X
-
Moody, S. E., Perez, D., Pan, T. C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D., & Chodosh, L. A. (2005). The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell, 8, 197-209. (Pubitemid 41317591)
-
(2005)
Cancer Cell
, vol.8
, Issue.3
, pp. 197-209
-
-
Moody, S.E.1
Perez, D.2
Pan, T.-C.3
Sarkisian, C.J.4
Portocarrero, C.P.5
Sterner, C.J.6
Notorfrancesco, K.L.7
Cardiff, R.D.8
Chodosh, L.A.9
-
39
-
-
84878583653
-
Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells
-
Fan, F., Samuel, S., Evans, K. W., Lu, J., Xia, L., Zhou, Y., Sceusi, E., Tozzi, F., Ye, X. C., Mani, S. A., & Ellis, L. M. (2012). Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Medical, 1, 5-16.
-
(2012)
Cancer Medical
, vol.1
, pp. 5-16
-
-
Fan, F.1
Samuel, S.2
Evans, K.W.3
Lu, J.4
Xia, L.5
Zhou, Y.6
Sceusi, E.7
Tozzi, F.8
Ye, X.C.9
Mani, S.A.10
Ellis, L.M.11
-
40
-
-
78649327371
-
Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines
-
Emadi Baygi, M., Soheili, Z. S., Schmitz, I., Sameie, S., & Schulz, W. A. (2010). Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines. Cell Biology and Toxicology, 26, 553-567.
-
(2010)
Cell Biology and Toxicology
, vol.26
, pp. 553-567
-
-
Emadi Baygi, M.1
Soheili, Z.S.2
Schmitz, I.3
Sameie, S.4
Schulz, W.A.5
-
41
-
-
77952921829
-
Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells
-
McKeithen, D., Graham, T., Chung, L. W., & Odero-Marah, V. (2010). Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells. Prostate, 70, 982-992.
-
(2010)
Prostate
, vol.70
, pp. 982-992
-
-
McKeithen, D.1
Graham, T.2
Chung, L.W.3
Odero-Marah, V.4
-
42
-
-
77954637769
-
Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines
-
Emadi Baygi, M., Soheili, Z. S., Essmann, F., Deezagi, A., Engers, R., Goering, W., & Schulz, W. A. (2010). Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines. Tumour Biology, 31, 297-307.
-
(2010)
Tumour Biology
, vol.31
, pp. 297-307
-
-
Emadi Baygi, M.1
Soheili, Z.S.2
Essmann, F.3
Deezagi, A.4
Engers, R.5
Goering, W.6
Schulz, W.A.7
-
43
-
-
84865582502
-
Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancer
-
Wu, K., Gore, C., Yang, L., Fazli, L., Gleave, M., Pong, R. C., Xiao, G., Zhang, L., Yun, E. J., Tseng, S. F., Kapur, P., He, D., & Hsieh, J. T. (2012). Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancer. Molecular Endocrinology, 26, 1496-1507.
-
(2012)
Molecular Endocrinology
, vol.26
, pp. 1496-1507
-
-
Wu, K.1
Gore, C.2
Yang, L.3
Fazli, L.4
Gleave, M.5
Pong, R.C.6
Xiao, G.7
Zhang, L.8
Yun, E.J.9
Tseng, S.F.10
Kapur, P.11
He, D.12
Hsieh, J.T.13
-
44
-
-
42049092980
-
Insulin-like growth factor-I - Dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells
-
DOI 10.1158/0008-5472.CAN-07-2559
-
Graham, T. R., Zhau, H. E., Odero-Marah, V. A., Osunkoya, A. O., Kimbro, K. S., Tighiouart, M., Liu, T., Simons, J. W., & O'Regan, R. M. (2008). Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Research, 68, 2479-2488. (Pubitemid 351521824)
-
(2008)
Cancer Research
, vol.68
, Issue.7
, pp. 2479-2488
-
-
Graham, T.R.1
Zhau, H.E.2
Odero-Marah, V.A.3
Osunkoya, A.O.4
Kimbro, K.S.5
Tighiouart, M.6
Liu, T.7
Simons, J.W.8
O'Regan, R.M.9
-
45
-
-
2942707848
-
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
-
DOI 10.1016/j.cell.2004.06.006, PII S0092867404005768
-
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939. (Pubitemid 38798858)
-
(2004)
Cell
, vol.117
, Issue.7
, pp. 927-939
-
-
Yang, J.1
Mani, S.A.2
Donaher, J.L.3
Ramaswamy, S.4
Itzykson, R.A.5
Come, C.6
Savagner, P.7
Gitelman, I.8
Richardson, A.9
Weinberg, R.A.10
-
46
-
-
84863481932
-
Twist expression associated with the epithelial-mesenchymal transition in gastric cancer
-
Liu, A. N., Zhu, Z. H., Chang, S. J., & Hang, X. S. (2012). Twist expression associated with the epithelial-mesenchymal transition in gastric cancer. Molecular and Cellular Biochemistry, 367, 195-203.
-
(2012)
Molecular and Cellular Biochemistry
, vol.367
, pp. 195-203
-
-
Liu, A.N.1
Zhu, Z.H.2
Chang, S.J.3
Hang, X.S.4
-
47
-
-
77957583439
-
Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition
-
Yang, M. H., Hsu, D. S., Wang, H. W., Wang, H. J., Lan, H. Y., Yang, W. H., Huang, C. H., Kao, S. Y., Tzeng, C. H., Tai, S. K., Chang, S. Y., Lee, O. K., & Wu, K. J. (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nature Cell Biology, 12, 982-992.
-
(2010)
Nature Cell Biology
, vol.12
, pp. 982-992
-
-
Yang, M.H.1
Hsu, D.S.2
Wang, H.W.3
Wang, H.J.4
Lan, H.Y.5
Yang, W.H.6
Huang, C.H.7
Kao, S.Y.8
Tzeng, C.H.9
Tai, S.K.10
Chang, S.Y.11
Lee, O.K.12
Wu, K.J.13
-
48
-
-
79952499030
-
Twist1-induced invadopodia formation promotes tumor metastasis
-
Eckert, M. A., Lwin, T. M., Chang, A. T., Kim, J., Danis, E., Ohno-Machado, L., & Yang, J. (2011). Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell, 19, 372-386.
-
(2011)
Cancer Cell
, vol.19
, pp. 372-386
-
-
Eckert, M.A.1
Lwin, T.M.2
Chang, A.T.3
Kim, J.4
Danis, E.5
Ohno-Machado, L.6
Yang, J.7
-
49
-
-
34249289041
-
Snail, ZEB and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
-
DOI 10.1038/nrc2131, PII NRC2131
-
Peinado, H., Olmeda, D., & Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nature Reviews Cancer, 7, 415-428. (Pubitemid 46809165)
-
(2007)
Nature Reviews Cancer
, vol.7
, Issue.6
, pp. 415-428
-
-
Peinado, H.1
Olmeda, D.2
Cano, A.3
-
50
-
-
34548856802
-
Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients
-
DOI 10.1158/1078-0432.CCR-07-0024
-
Watson, M. A., Ylagan, L. R., Trinkaus, K. M., Gillanders, W. E., Naughton, M. J., Weilbaecher, K. N., Fleming, T. P., & Aft, R. L. (2007). Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clinical Cancer Research, 13, 5001-5009. (Pubitemid 47502064)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.17
, pp. 5001-5009
-
-
Watson, M.A.1
Ylagan, L.R.2
Trinkaus, K.M.3
Gillanders, W.E.4
Naughton, M.J.5
Weilbaecher, K.N.6
Fleming, T.P.7
Aft, R.L.8
-
51
-
-
33645733588
-
N-Cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1
-
Alexander, N. R., Tran, N. L., Rekapally, H., Summers, C. E., Glackin, C., & Heimark, R. L. (2006). N-Cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Research, 66, 3365-3369.
-
(2006)
Cancer Research
, vol.66
, pp. 3365-3369
-
-
Alexander, N.R.1
Tran, N.L.2
Rekapally, H.3
Summers, C.E.4
Glackin, C.5
Heimark, R.L.6
-
52
-
-
1542353401
-
Control of apoptosis by p53
-
Fridman, J. S., & Lowe, S. W. (2003). Control of apoptosis by p53. Oncogene, 22, 9030-9040.
-
(2003)
Oncogene
, vol.22
, pp. 9030-9040
-
-
Fridman, J.S.1
Lowe, S.W.2
-
53
-
-
0034703742
-
p53: Death star
-
Vousden, K. H. (2000). p53: Death star. Cell, 103, 691-694.
-
(2000)
Cell
, vol.103
, pp. 691-694
-
-
Vousden, K.H.1
-
54
-
-
0034671945
-
Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome
-
Sigal, A., & Rotter, V. (2000). Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Research, 60, 6788-6793.
-
(2000)
Cancer Research
, vol.60
, pp. 6788-6793
-
-
Sigal, A.1
Rotter, V.2
-
55
-
-
79952283482
-
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
-
Chang, C. J., Chao, C. H., Xia, W., Yang, J. Y., Xiong, Y., Li, C. W., Yu, W. H., Rehman, S. K., Hsu, J. L., Lee, H. H., Liu, M., Chen, C. T., Yu, D., & Hung, M. C. (2011). p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biology, 13, 317-323.
-
(2011)
Nature Cell Biology
, vol.13
, pp. 317-323
-
-
Chang, C.J.1
Chao, C.H.2
Xia, W.3
Yang, J.Y.4
Xiong, Y.5
Li, C.W.6
Yu, W.H.7
Rehman, S.K.8
Hsu, J.L.9
Lee, H.H.10
Liu, M.11
Chen, C.T.12
Yu, D.13
Hung, M.C.14
-
56
-
-
23144464750
-
Id family of helix-loop-helix proteins in cancer
-
DOI 10.1038/nrc1673
-
Perk, J., Iavarone, A., & Benezra, R. (2005). Id family of helix-loop-helix proteins in cancer. Nature Reviews Cancer, 5, 603-614. (Pubitemid 41081386)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.8
, pp. 603-614
-
-
Perk, J.1
Iavarone, A.2
Benezra, R.3
-
57
-
-
0036093103
-
Over expression of ID-1 in prostate cancer
-
Ouyang, X. S., Wang, X., Lee, D. T., Tsao, S. W., & Wong, Y. C. (2002). Over expression of ID-1 in prostate cancer. The Journal of Urology, 167, 2598-2602. (Pubitemid 34533187)
-
(2002)
Journal of Urology
, vol.167
, Issue.6
, pp. 2598-2602
-
-
Ouyang, X.S.1
Wang, X.2
Lee, D.T.W.3
Tsao, S.W.4
Wong, Y.C.5
-
58
-
-
36348964327
-
Identification of a novel Inhibitor of Differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells
-
DOI 10.1074/jbc.M705089200
-
Zhang, X., Ling, M. T., Wang, Q., Lau, C. K., Leung, S. C., Lee, T. K., Cheung, A. L., Wong, Y. C., & Wang, X. (2007). Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. The Journal of Biological Chemistry, 282, 33284-33294. (Pubitemid 350159546)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.46
, pp. 33284-33294
-
-
Zhang, X.1
Ling, M.-T.2
Wang, Q.3
Lau, C.-K.4
Leung, S.C.L.5
Lee, T.K.6
Cheung, A.L.M.7
Wong, Y.-C.8
Wang, X.9
-
59
-
-
13644266312
-
Caveolin-1 in oncogenic transformation, cancer, and metastasis
-
Williams, T. M., & Lisanti, M. P. (2005). Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology. Cell Physiology, 288, C494-C506.
-
(2005)
American Journal of Physiology. Cell Physiology
, vol.288
-
-
Williams, T.M.1
Lisanti, M.P.2
-
60
-
-
0033571471
-
Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
-
Yang, G., Truong, L. D., Wheeler, T. M., & Thompson, T. C. (1999). Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Research, 59, 5719-5723.
-
(1999)
Cancer Research
, vol.59
, pp. 5719-5723
-
-
Yang, G.1
Truong, L.D.2
Wheeler, T.M.3
Thompson, T.C.4
-
61
-
-
0345491598
-
Caveolin-1 Maintains Activated Akt in Prostate Cancer Cells through Scaffolding Domain Binding Site Interactions with and Inhibition of Serine/Threonine Protein Phosphatases PP1 and PP2A
-
DOI 10.1128/MCB.23.24.9389-9404.2003
-
Li, L., Ren, C. H., Tahir, S. A., Ren, C., & Thompson, T. C. (2003). Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Molecular and Cellular Biology, 23, 9389-9404. (Pubitemid 37499824)
-
(2003)
Molecular and Cellular Biology
, vol.23
, Issue.24
, pp. 9389-9404
-
-
Li, L.1
Ren, C.H.2
Tahir, S.A.3
Ren, C.4
Thompson, T.C.5
-
62
-
-
33947538812
-
Phosphatidylinositol 3-kinase-AKTmammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer
-
Wu, C., & Huang, J. (2007). Phosphatidylinositol 3-kinase- AKTmammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer. The Journal of Biological Chemistry, 282, 3571-3583.
-
(2007)
The Journal of Biological Chemistry
, vol.282
, pp. 3571-3583
-
-
Wu, C.1
Huang, J.2
-
63
-
-
84861576558
-
Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/beta- catenin signaling in prostate cancer cells
-
Ciarlo, M., Benelli, R., Barbieri, O., Minghelli, S., Barboro, P., Balbi, C., & Ferrari, N. (2012). Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/beta-catenin signaling in prostate cancer cells. International Journal of Cancer, 131, 582-590.
-
(2012)
International Journal of Cancer
, vol.131
, pp. 582-590
-
-
Ciarlo, M.1
Benelli, R.2
Barbieri, O.3
Minghelli, S.4
Barboro, P.5
Balbi, C.6
Ferrari, N.7
-
64
-
-
84874239421
-
Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase
-
Murthy, S., Wu, M., Bai, V. U., Hou, Z., Menon, M., Barrack, E. R., Kim, S. H., & Reddy, G. P. (2013). Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase. PLoS One, 8, e56692.
-
(2013)
PLoS One
, vol.8
-
-
Murthy, S.1
Wu, M.2
Bai, V.U.3
Hou, Z.4
Menon, M.5
Barrack, E.R.6
Kim, S.H.7
Reddy, G.P.8
-
65
-
-
84862908058
-
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: Implications for androgendeprivation therapy
-
Sun, Y., Wang, B. E., Leong, K. G., Yue, P., Li, L., Jhunjhunwala, S., Chen, D., Seo, K., Modrusan, Z., Gao, W. Q., Settleman, J., & Johnson, L. (2012). Androgen deprivation causes epithelial-mesenchymal transition in the prostate: Implications for androgendeprivation therapy. Cancer Research, 72, 527-536.
-
(2012)
Cancer Research
, vol.72
, pp. 527-536
-
-
Sun, Y.1
Wang, B.E.2
Leong, K.G.3
Yue, P.4
Li, L.5
Jhunjhunwala, S.6
Chen, D.7
Seo, K.8
Modrusan, Z.9
Gao, W.Q.10
Settleman, J.11
Johnson, L.12
-
66
-
-
84873035468
-
TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells
-
Eide, T., Ramberg, H., Glackin, C., Tindall, D., & Tasken, K. A. (2013). TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells. Cancer Cell International, 13, 4.
-
(2013)
Cancer Cell International
, vol.13
, pp. 4
-
-
Eide, T.1
Ramberg, H.2
Glackin, C.3
Tindall, D.4
Tasken, K.A.5
-
67
-
-
84867024120
-
Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development
-
Lu, T., Lin, W. J., Izumi, K., Wang, X., Xu, D., Fang, L. Y., Li, L., Jiang, Q., Jin, J., & Chang, C. (2012). Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. Molecular Endocrinology, 26, 1707-1715.
-
(2012)
Molecular Endocrinology
, vol.26
, pp. 1707-1715
-
-
Lu, T.1
Lin, W.J.2
Izumi, K.3
Wang, X.4
Xu, D.5
Fang, L.Y.6
Li, L.7
Jiang, Q.8
Jin, J.9
Chang, C.10
-
68
-
-
38449120211
-
Role of PTEN gene in progression of prostate cancer
-
Spring
-
Pourmand, G., Ziaee, A. A., Abedi, A. R., Mehrsai, A., Alavi, H. A., Ahmadi, A., & Saadati, H. R. (2007). Role of PTEN gene in progression of prostate cancer. Urology Journal, 4, 95-100. Spring.
-
(2007)
Urology Journal
, vol.4
, pp. 95-100
-
-
Pourmand, G.1
Ziaee, A.A.2
Abedi, A.R.3
Mehrsai, A.4
Alavi, H.A.5
Ahmadi, A.6
Saadati, H.R.7
-
69
-
-
84859416889
-
Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells
-
Mulholland, D. J., Kobayashi, N., Ruscetti, M., Zhi, A., Tran, L. M., Huang, J., Gleave, M., & Wu, H. (2012). Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Research, 72, 1878-1889.
-
(2012)
Cancer Research
, vol.72
, pp. 1878-1889
-
-
Mulholland, D.J.1
Kobayashi, N.2
Ruscetti, M.3
Zhi, A.4
Tran, L.M.5
Huang, J.6
Gleave, M.7
Wu, H.8
-
70
-
-
58549108859
-
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
-
Dubrovska, A., Kim, S., Salamone, R. J., Walker, J. R., Maira, S. M., Garcia-Echeverria, C., Schultz, P. G., & Reddy, V. A. (2009). The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proceedings of the National Academy of Sciences of the United States of America, 106, 268-273.
-
(2009)
Proceedings of the National Academy of Sciences of the United States of America
, vol.106
, pp. 268-273
-
-
Dubrovska, A.1
Kim, S.2
Salamone, R.J.3
Walker, J.R.4
Maira, S.M.5
Garcia-Echeverria, C.6
Schultz, P.G.7
Reddy, V.A.8
-
71
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., Antipin, Y., Mitsiades, N., Landers, T., Dolgalev, I., Major, J. E., Wilson, M., Socci, N. D., Lash, A. E., Heguy, A., Eastham, J. A., Scher, H. I., Reuter, V. E., Scardino, P. T., Sander, C., Sawyers, C. L., & Gerald, W. L. (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell, 18, 11-22.
-
(2010)
Cancer Cell
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
Schultz, N.2
Hieronymus, H.3
Gopalan, A.4
Xiao, Y.5
Carver, B.S.6
Arora, V.K.7
Kaushik, P.8
Cerami, E.9
Reva, B.10
Antipin, Y.11
Mitsiades, N.12
Landers, T.13
Dolgalev, I.14
Major, J.E.15
Wilson, M.16
Socci, N.D.17
Lash, A.E.18
Heguy, A.19
Eastham, J.A.20
Scher, H.I.21
Reuter, V.E.22
Scardino, P.T.23
Sander, C.24
Sawyers, C.L.25
Gerald, W.L.26
more..
-
72
-
-
84862207240
-
Three decades of Wnts: A personal perspective on how a scientific field developed
-
Nusse, R., & Varmus, H. (2012). Three decades of Wnts: A personal perspective on how a scientific field developed. EMBO Journal, 31, 2670-2684.
-
(2012)
EMBO Journal
, vol.31
, pp. 2670-2684
-
-
Nusse, R.1
Varmus, H.2
-
73
-
-
77953695990
-
The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
-
Yee, D. S., Tang, Y., Li, X., Liu, Z., Guo, Y., Ghaffar, S., McQueen, P., Atreya, D., Xie, J., Simoneau, A. R., Hoang, B. H., & Zi, X. (2010). The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Molecular Cancer, 9, 162.
-
(2010)
Molecular Cancer
, vol.9
, pp. 162
-
-
Yee, D.S.1
Tang, Y.2
Li, X.3
Liu, Z.4
Guo, Y.5
Ghaffar, S.6
McQueen, P.7
Atreya, D.8
Xie, J.9
Simoneau, A.R.10
Hoang, B.H.11
Zi, X.12
-
74
-
-
33746808398
-
Wnt/beta-catenin signaling in development and disease
-
Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
-
(2006)
Cell
, vol.127
, pp. 469-480
-
-
Clevers, H.1
-
75
-
-
0034283030
-
Beta-catenin affects androgen receptor transcriptional activity and ligand specificity
-
Truica, C. I., Byers, S., & Gelmann, E. P. (2000). Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Research, 60, 4709-4713.
-
(2000)
Cancer Research
, vol.60
, pp. 4709-4713
-
-
Truica, C.I.1
Byers, S.2
Gelmann, E.P.3
-
76
-
-
48749129835
-
Alterations in beta-catenin expression and localization in prostate cancer
-
Whitaker, H. C., Girling, J., Warren, A. Y., Leung, H., Mills, I. G., & Neal, D. E. (2008). Alterations in beta-catenin expression and localization in prostate cancer. Prostate, 68, 1196-1205.
-
(2008)
Prostate
, vol.68
, pp. 1196-1205
-
-
Whitaker, H.C.1
Girling, J.2
Warren, A.Y.3
Leung, H.4
Mills, I.G.5
Neal, D.E.6
-
77
-
-
84863011082
-
Activation of beta-catenin signaling in androgen receptor-negative prostate cancer cells
-
Wan, X., Liu, J., Lu, J. F., Tzelepi, V., Yang, J., Starbuck, M. W., Diao, L., Wang, J., Efstathiou, E., Vazquez, E. S., Troncoso, P., Maity, S. N., & Navone, N. M. (2012). Activation of beta-catenin signaling in androgen receptor-negative prostate cancer cells. Clinical Cancer Research, 18, 726-736.
-
(2012)
Clinical Cancer Research
, vol.18
, pp. 726-736
-
-
Wan, X.1
Liu, J.2
Lu, J.F.3
Tzelepi, V.4
Yang, J.5
Starbuck, M.W.6
Diao, L.7
Wang, J.8
Efstathiou, E.9
Vazquez, E.S.10
Troncoso, P.11
Maity, S.N.12
Navone, N.M.13
-
78
-
-
44449173164
-
Membrane type 1 matrix metalloproteinase induces epithelial-to- mesenchymal transition in prostate cancer
-
Cao, J., Chiarelli, C., Richman, O., Zarrabi, K., Kozarekar, P., & Zucker, S. (2008). Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. The Journal of Biological Chemistry, 283, 6232-6240.
-
(2008)
The Journal of Biological Chemistry
, vol.283
, pp. 6232-6240
-
-
Cao, J.1
Chiarelli, C.2
Richman, O.3
Zarrabi, K.4
Kozarekar, P.5
Zucker, S.6
-
79
-
-
77249104533
-
Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis
-
Xie, D., Gore, C., Liu, J., Pong, R. C., Mason, R., Hao, G., Long, M., Kabbani, W., Yu, L., Zhang, H., Chen, H., Sun, X., Boothman, D. A., Min, W., & Hsieh, J. T. (2010). "Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis,". Proceedings of the National Academy of Sciences of the United States of America, 107, 2485-2490.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 2485-2490
-
-
Xie, D.1
Gore, C.2
Liu, J.3
Pong, R.C.4
Mason, R.5
Hao, G.6
Long, M.7
Kabbani, W.8
Yu, L.9
Zhang, H.10
Chen, H.11
Sun, X.12
Boothman, D.A.13
Min, W.14
Hsieh, J.T.15
-
80
-
-
77749297990
-
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB
-
Min, J., Zaslavsky, A., Fedele, G., McLaughlin, S. K., Reczek, E. E., De Raedt, T., Guney, I., Strochlic, D. E., Macconaill, L. E., Beroukhim, R., Bronson, R. T., Ryeom, S., Hahn, W. C., Loda, M., & Cichowski, K. (2010). "An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nature Medicine, 16, 286-294.
-
(2010)
Nature Medicine
, vol.16
, pp. 286-294
-
-
Min, J.1
Zaslavsky, A.2
Fedele, G.3
McLaughlin, S.K.4
Reczek, E.E.5
De Raedt, T.6
Guney, I.7
Strochlic, D.E.8
Macconaill, L.E.9
Beroukhim, R.10
Bronson, R.T.11
Ryeom, S.12
Hahn, W.C.13
Loda, M.14
Cichowski, K.15
-
81
-
-
84899440424
-
The role of DAB2IP in androgen receptor activation during prostate cancer progression
-
Apr 22
-
K. Wu, J. Liu, S. F. Tseng, C. Gore, Z. Ning, N. Sharifi, L. Fazli, M. Gleave, P. Kapur, G. Xiao, X. Sun, O. K. Oz, W. Min, G. Alexandrakis, C. R. Yang, C. L. Hsieh, H. C. Wu, D. He, D. Xie, and J. T. Hsieh, "The role of DAB2IP in androgen receptor activation during prostate cancer progression," Oncogene, Apr 22 2013.
-
(2013)
Oncogene
-
-
Wu, K.1
Liu, J.2
Tseng, S.F.3
Gore, C.4
Ning, Z.5
Sharifi, N.6
Fazli, L.7
Gleave, M.8
Kapur, P.9
Xiao, G.10
Sun, X.11
Oz, O.K.12
Min, W.13
Alexandrakis, G.14
Yang, C.R.15
Hsieh, C.L.16
Wu, H.C.17
He, D.18
Xie, D.19
Hsieh, J.T.20
more..
-
82
-
-
84861611628
-
NF-kappaB signaling in prostate cancer: A promising therapeutic target?
-
Jain, G., Cronauer, M. V., Schrader, M., Moller, P., & Marienfeld, R. B. (2012). NF-kappaB signaling in prostate cancer: a promising therapeutic target? World Journal of Urology, 30, 303-310.
-
(2012)
World Journal of Urology
, vol.30
, pp. 303-310
-
-
Jain, G.1
Cronauer, M.V.2
Schrader, M.3
Moller, P.4
Marienfeld, R.B.5
-
83
-
-
84867847457
-
NFkappaB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression
-
McCall, P., Bennett, L., Ahmad, I., Mackenzie, L. M., Forbes, I. W., Leung, H. Y., Sansom, O. J., Orange, C., Seywright, M., Underwood, M. A., & Edwards, J. (2012). NFkappaB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. British Journal of Cancer, 107, 1554-1563.
-
(2012)
British Journal of Cancer
, vol.107
, pp. 1554-1563
-
-
McCall, P.1
Bennett, L.2
Ahmad, I.3
Mackenzie, L.M.4
Forbes, I.W.5
Leung, H.Y.6
Sansom, O.J.7
Orange, C.8
Seywright, M.9
Underwood, M.A.10
Edwards, J.11
-
84
-
-
45149092780
-
NF-kappaB and epithelial to mesenchymal transition of cancer
-
DOI 10.1002/jcb.21695
-
Min, C., Eddy, S. F., Sherr, D. H., & Sonenshein, G. E. (2008). NFkappaB and epithelial to mesenchymal transition of cancer. Journal of Cellular Biochemistry, 104, 733-744. (Pubitemid 351830825)
-
(2008)
Journal of Cellular Biochemistry
, vol.104
, Issue.3
, pp. 733-744
-
-
Min, C.1
Eddy, S.F.2
Sherr, D.H.3
Sonenshein, G.E.4
-
85
-
-
34247274248
-
Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin
-
DOI 10.1038/nature05656, PII NATURE05656
-
Luo, J. L., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A., & Karin, M. (2007). Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature, 446, 690-694. (Pubitemid 46606879)
-
(2007)
Nature
, vol.446
, Issue.7136
, pp. 690-694
-
-
Luo, J.-L.1
Tan, W.2
Ricono, J.M.3
Korchynskyi, O.4
Zhang, M.5
Gonias, S.L.6
Cheresh, D.A.7
Karin, M.8
-
86
-
-
49149114127
-
Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
-
Odero-Marah, V. A., Wang, R., Chu, G., Zayzafoon, M., Xu, J., Shi, C., Marshall, F. F., Zhau, H. E., & Chung, L. W. (2008). Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Research, 18, 858-870.
-
(2008)
Cell Research
, vol.18
, pp. 858-870
-
-
Odero-Marah, V.A.1
Wang, R.2
Chu, G.3
Zayzafoon, M.4
Xu, J.5
Shi, C.6
Marshall, F.F.7
Zhau, H.E.8
Chung, L.W.9
-
87
-
-
84870357109
-
CXCL1/GROalpha increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-kappaB/HDAC1 epigenetic regulation
-
Kuo, P. L., Shen, K. H., Hung, S. H., & Hsu, Y. L. (2012). CXCL1/GROalpha increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-kappaB/HDAC1 epigenetic regulation. Carcinogenesis, 33, 2477-2487.
-
(2012)
Carcinogenesis
, vol.33
, pp. 2477-2487
-
-
Kuo, P.L.1
Shen, K.H.2
Hung, S.H.3
Hsu, Y.L.4
-
88
-
-
78649854761
-
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
-
Bolitho, C., Hahn, M. A., Baxter, R. C., & Marsh, D. J. (2010). The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor. Endocrine-Related Cancer, 17, 929-940.
-
(2010)
Endocrine-Related Cancer
, vol.17
, pp. 929-940
-
-
Bolitho, C.1
Hahn, M.A.2
Baxter, R.C.3
Marsh, D.J.4
-
89
-
-
84867568900
-
Clusterin mediates TGF-beta-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells
-
Shiota, M., Zardan, A., Takeuchi, A., Kumano, M., Beraldi, E., Naito, S., Zoubeidi, A., & Gleave, M. E. (2012). Clusterin mediates TGF-beta-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells. Cancer Research, 72, 5261-5272.
-
(2012)
Cancer Research
, vol.72
, pp. 5261-5272
-
-
Shiota, M.1
Zardan, A.2
Takeuchi, A.3
Kumano, M.4
Beraldi, E.5
Naito, S.6
Zoubeidi, A.7
Gleave, M.E.8
-
90
-
-
77950476293
-
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: Implications for Gleason grading
-
Mak, P., Leav, I., Pursell, B., Bae, D., Yang, X., Taglienti, C. A., Gouvin, L. M., Sharma, V. M., & Mercurio, A. M. (2010). ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell, 17, 319-332.
-
(2010)
Cancer Cell
, vol.17
, pp. 319-332
-
-
Mak, P.1
Leav, I.2
Pursell, B.3
Bae, D.4
Yang, X.5
Taglienti, C.A.6
Gouvin, L.M.7
Sharma, V.M.8
Mercurio, A.M.9
-
91
-
-
0034719136
-
Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state
-
Poon, S., Easterbrook-Smith, S. B., Rybchyn, M. S., Carver, J. A., & Wilson, M. R. (2000). Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry, 39, 15953 - 15960.
-
(2000)
Biochemistry
, vol.39
, pp. 15953-15960
-
-
Poon, S.1
Easterbrook-Smith, S.B.2
Rybchyn, M.S.3
Carver, J.A.4
Wilson, M.R.5
-
92
-
-
77957957234
-
Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castrationresistant prostate cancer
-
Chi, K. N., Hotte, S. J., Yu, E. Y., Tu, D., Eigl, B. J., Tannock, I., Saad, F., North, S., Powers, J., Gleave, M. E., & Eisenhauer, E. A. (2010). Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castrationresistant prostate cancer. Journal of Clinical Oncology, 28, 4247-4254.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 4247-4254
-
-
Chi, K.N.1
Hotte, S.J.2
Yu, E.Y.3
Tu, D.4
Eigl, B.J.5
Tannock, I.6
Saad, F.7
North, S.8
Powers, J.9
Gleave, M.E.10
Eisenhauer, E.A.11
-
93
-
-
76749144766
-
Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer
-
Zoubeidi, A., Chi, K., & Gleave, M. (2010). Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer. Clinical Cancer Research, 16, 1088-1093.
-
(2010)
Clinical Cancer Research
, vol.16
, pp. 1088-1093
-
-
Zoubeidi, A.1
Chi, K.2
Gleave, M.3
-
94
-
-
33847069683
-
The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer
-
Turley, R. S., Finger, E. C., Hempel, N., How, T., Fields, T. A., & Blobe, G. C. (2007). The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. Cancer Research, 67, 1090-1098.
-
(2007)
Cancer Research
, vol.67
, pp. 1090-1098
-
-
Turley, R.S.1
Finger, E.C.2
Hempel, N.3
How, T.4
Fields, T.A.5
Blobe, G.C.6
-
95
-
-
77952896646
-
TGFbeta signalling: A complex web in cancer progression
-
Ikushima, H., & Miyazono, K. (2010). TGFbeta signalling: a complex web in cancer progression. Nature Reviews Cancer, 10, 415-424.
-
(2010)
Nature Reviews Cancer
, vol.10
, pp. 415-424
-
-
Ikushima, H.1
Miyazono, K.2
-
96
-
-
63049136592
-
A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis
-
Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., Parenti, A. R., Rosato, A., Bicciato, S., Balmain, A., & Piccolo, S. (2009). A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell, 137, 87-98.
-
(2009)
Cell
, vol.137
, pp. 87-98
-
-
Adorno, M.1
Cordenonsi, M.2
Montagner, M.3
Dupont, S.4
Wong, C.5
Hann, B.6
Solari, A.7
Bobisse, S.8
Rondina, M.B.9
Guzzardo, V.10
Parenti, A.R.11
Rosato, A.12
Bicciato, S.13
Balmain, A.14
Piccolo, S.15
-
97
-
-
79951512852
-
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
-
Ding, Z., Wu, C. J., Chu, G. C., Xiao, Y., Ho, D., Zhang, J., Perry, S. R., Labrot, E. S., Wu, X., Lis, R., Hoshida, Y., Hiller, D., Hu, B., Jiang, S., Zheng, H., Stegh, A. H., Scott, K. L., Signoretti, S., Bardeesy, N., Wang, Y. A., Hill, D. E., Golub, T. R., Stampfer, M. J., Wong, W. H., Loda, M., Mucci, L., Chin, L., & DePinho, R. A. (2011). SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature, 470, 269- 273.
-
(2011)
Nature
, vol.470
, pp. 269-273
-
-
Ding, Z.1
Wu, C.J.2
Chu, G.C.3
Xiao, Y.4
Ho, D.5
Zhang, J.6
Perry, S.R.7
Labrot, E.S.8
Wu, X.9
Lis, R.10
Hoshida, Y.11
Hiller, D.12
Hu, B.13
Jiang, S.14
Zheng, H.15
Stegh, A.H.16
Scott, K.L.17
Signoretti, S.18
Bardeesy, N.19
Wang, Y.A.20
Hill, D.E.21
Golub, T.R.22
Stampfer, M.J.23
Wong, W.H.24
Loda, M.25
Mucci, L.26
Chin, L.27
DePinho, R.A.28
more..
-
98
-
-
84872161627
-
COUP-TFII inhibits TGF-beta-induced growth barrier to promote prostate tumorigenesis
-
Qin, J., Wu, S. P., Creighton, C. J., Dai, F., Xie, X., Cheng, C. M., Frolov, A., Ayala, G., Lin, X., Feng, X. H., Ittmann, M. M., Tsai, S. J., Tsai, M. J., & Tsai, S. Y. (2013). COUP-TFII inhibits TGF-beta-induced growth barrier to promote prostate tumorigenesis. Nature, 493, 236-240.
-
(2013)
Nature
, vol.493
, pp. 236-240
-
-
Qin, J.1
Wu, S.P.2
Creighton, C.J.3
Dai, F.4
Xie, X.5
Cheng, C.M.6
Frolov, A.7
Ayala, G.8
Lin, X.9
Feng, X.H.10
Ittmann, M.M.11
Tsai, S.J.12
Tsai, M.J.13
Tsai, S.Y.14
-
99
-
-
36348960224
-
TGF-beta and BMP7 interactions in tumour progression and bone metastasis
-
DOI 10.1007/s10585-007-9118-2
-
Buijs, J. T., Henriquez, N. V., van Overveld, P. G., van der Horst, G., ten Dijke, P., & van der Pluijm, G. (2007). TGF-beta and BMP7 interactions in tumour progression and bone metastasis. Clinical & Experimental Metastasis, 24, 609-617. (Pubitemid 50003597)
-
(2007)
Clinical and Experimental Metastasis
, vol.24
, Issue.8
, pp. 609-617
-
-
Buijs, J.T.1
Henriquez, N.V.2
Van Overveld, P.G.M.3
Van Der, H.G.4
Ten, D.P.5
Van Der, P.G.6
-
100
-
-
58649108302
-
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer
-
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G. Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., & Karin, M. (2009). IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell, 15, 103-113.
-
(2009)
Cancer Cell
, vol.15
, pp. 103-113
-
-
Grivennikov, S.1
Karin, E.2
Terzic, J.3
Mucida, D.4
Yu, G.Y.5
Vallabhapurapu, S.6
Scheller, J.7
Rose-John, S.8
Cheroutre, H.9
Eckmann, L.10
Karin, M.11
-
101
-
-
58649101347
-
gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis
-
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, O., Schwitalla, S., Matthews, V., Schmid, R. M., Kirchner, T., Arkan, M. C., Ernst, M., & Greten, F. R. (2009). gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell, 15, 91-102.
-
(2009)
Cancer Cell
, vol.15
, pp. 91-102
-
-
Bollrath, J.1
Phesse, T.J.2
Von Burstin, V.A.3
Putoczki, T.4
Bennecke, M.5
Bateman, T.6
Nebelsiek, T.7
Lundgren-May, T.8
Canli, O.9
Schwitalla, S.10
Matthews, V.11
Schmid, R.M.12
Kirchner, T.13
Arkan, M.C.14
Ernst, M.15
Greten, F.R.16
-
102
-
-
84055207487
-
IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway
-
Yadav, A., Kumar, B., Datta, J., Teknos, T. N., & Kumar, P. (2011). IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Molecular Cancer Research, 9, 1658-1667.
-
(2011)
Molecular Cancer Research
, vol.9
, pp. 1658-1667
-
-
Yadav, A.1
Kumar, B.2
Datta, J.3
Teknos, T.N.4
Kumar, P.5
-
103
-
-
77957273623
-
TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
-
Yao, Z., Fenoglio, S., Gao, D. C., Camiolo, M., Stiles, B., Lindsted, T., Schlederer, M., Johns, C., Altorki, N., Mittal, V., Kenner, L., & Sordella, R. (2010). TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proceedings of the National Academy of Sciences of the United States of America, 107, 15535-15540.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 15535-15540
-
-
Yao, Z.1
Fenoglio, S.2
Gao, D.C.3
Camiolo, M.4
Stiles, B.5
Lindsted, T.6
Schlederer, M.7
Johns, C.8
Altorki, N.9
Mittal, V.10
Kenner, L.11
Sordella, R.12
-
104
-
-
69249221254
-
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
-
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V., Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009). Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene, 28, 2940-2947.
-
(2009)
Oncogene
, vol.28
, pp. 2940-2947
-
-
Sullivan, N.J.1
Sasser, A.K.2
Axel, A.E.3
Vesuna, F.4
Raman, V.5
Ramirez, N.6
Oberyszyn, T.M.7
Hall, B.M.8
-
105
-
-
0026670336
-
Active cell death in hormonedependent tissues
-
Tenniswood, M. P., Guenette, R. S., Lakins, J., Mooibroek, M., Wong, P., & Welsh, J. E. (1992). Active cell death in hormonedependent tissues. Cancer Metastasis Reviews, 11, 197-220.
-
(1992)
Cancer Metastasis Reviews
, vol.11
, pp. 197-220
-
-
Tenniswood, M.P.1
Guenette, R.S.2
Lakins, J.3
Mooibroek, M.4
Wong, P.5
Welsh, J.E.6
-
106
-
-
0036143720
-
Hsp27 as a negative regulator of cytochrome c release
-
Paul, C., Manero, F., Gonin, S., Kretz-Remy, C., Virot, S., & Arrigo, A. P. (2002). Hsp27 as a negative regulator of cytochrome C release. Molecular and Cellular Biology, 22, 816-834. (Pubitemid 34053061)
-
(2002)
Molecular and Cellular Biology
, vol.22
, Issue.3
, pp. 816-834
-
-
Paul, C.1
Manero, F.2
Gonin, S.3
Kretz-Remy, C.4
Virot, S.5
Arrigo, A.-P.6
-
108
-
-
84877855030
-
Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer
-
Shiota, M., Bishop, J. L., Nip, K. M., Zardan, A., Takeuchi, A., Cordonnier, T., Beraldi, E., Bazov, J., Fazli, L., Chi, K., Gleave, M., & Zoubeidi, A. (2013). Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. Cancer Research, 73, 3109-3119.
-
(2013)
Cancer Research
, vol.73
, pp. 3109-3119
-
-
Shiota, M.1
Bishop, J.L.2
Nip, K.M.3
Zardan, A.4
Takeuchi, A.5
Cordonnier, T.6
Beraldi, E.7
Bazov, J.8
Fazli, L.9
Chi, K.10
Gleave, M.11
Zoubeidi, A.12
-
109
-
-
81155137295
-
LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling
-
Lue, H. W., Yang, X., Wang, R., Qian, W., Xu, R. Z., Lyles, R., Osunkoya, A. O., Zhou, B. P., Vessella, R. L., Zayzafoon, M., Liu, Z. R., Zhau, H. E., & Chung, L. W. (2011). LIV-1 promotes prostate cancer epithelial-to- mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS One, 6, e27720.
-
(2011)
PLoS One
, vol.6
-
-
Lue, H.W.1
Yang, X.2
Wang, R.3
Qian, W.4
Xu, R.Z.5
Lyles, R.6
Osunkoya, A.O.7
Zhou, B.P.8
Vessella, R.L.9
Zayzafoon, M.10
Liu, Z.R.11
Zhau, H.E.12
Chung, L.W.13
-
110
-
-
77954604008
-
Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer
-
Mimeault, M., & Batra, S. K. (2010). Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer. Journal of Cellular Physiology, 224, 626-635.
-
(2010)
Journal of Cellular Physiology
, vol.224
, pp. 626-635
-
-
Mimeault, M.1
Batra, S.K.2
-
111
-
-
4344567388
-
Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis
-
DOI 10.1158/0008-5472.CAN-04-1216
-
Cheung, P. K., Woolcock, B., Adomat, H., Sutcliffe, M., Bainbridge, T. C., Jones, E. C., Webber, D., Kinahan, T., Sadar, M., Gleave, M. E., & Vielkind, J. (2004). Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Research, 64, 5929-5933. (Pubitemid 39129386)
-
(2004)
Cancer Research
, vol.64
, Issue.17
, pp. 5929-5933
-
-
Cheung, P.K.1
Woolcock, B.2
Adomat, H.3
Sutcliffe, M.4
Bainbridge, T.C.5
Jones, E.C.6
Webber, D.7
Kinahan, T.8
Sadar, M.9
Gleave, M.E.10
Vielkind, J.11
-
112
-
-
0038076012
-
Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues
-
DOI 10.1038/sj.bjc.6600869
-
Nakamura, T., Scorilas, A., Stephan, C., Yousef, G. M., Kristiansen, G., Jung, K., & Diamandis, E. P. (2003). Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. British Journal of Cancer, 88, 1101-1104. (Pubitemid 36560783)
-
(2003)
British Journal of Cancer
, vol.88
, Issue.7
, pp. 1101-1104
-
-
Nakamura, T.1
Scorilas, A.2
Stephan, C.3
Yousef, G.M.4
Kristiansen, G.5
Jung, K.6
Diamandis, E.P.7
-
113
-
-
26944435866
-
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells
-
DOI 10.1677/erc.1.00958
-
Veveris-Lowe, T. L., Lawrence, M. G., Collard, R. L., Bui, L., Herington, A. C., Nicol, D. L., & Clements, J. A. (2005). Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocrine-Related Cancer, 12, 631-643. (Pubitemid 41482997)
-
(2005)
Endocrine-Related Cancer
, vol.12
, Issue.3
, pp. 631-643
-
-
Veveris-Lowe, T.L.1
Lawrence, M.G.2
Collard, R.L.3
Bui, L.4
Herington, A.C.5
Nicol, D.L.6
Clements, J.A.7
-
114
-
-
79951578844
-
UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction
-
Jang, M. J., Baek, S. H., & Kim, J. H. (2011). UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction. Cancer Letters, 302, 128-135.
-
(2011)
Cancer Letters
, vol.302
, pp. 128-135
-
-
Jang, M.J.1
Baek, S.H.2
Kim, J.H.3
-
115
-
-
79959713140
-
Fibroblast growth factors and their receptors in cancer
-
Wesche, J., Haglund, K., & Haugsten, E. M. (2011). Fibroblast growth factors and their receptors in cancer. The Biochemical Journal, 437, 199-213.
-
(2011)
The Biochemical Journal
, vol.437
, pp. 199-213
-
-
Wesche, J.1
Haglund, K.2
Haugsten, E.M.3
-
116
-
-
0030665570
-
Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells
-
Feng, S., Wang, F., Matsubara, A., Kan, M., & McKeehan, W. L. (1997). Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Research, 57, 5369-5378. (Pubitemid 27516376)
-
(1997)
Cancer Research
, vol.57
, Issue.23
, pp. 5369-5378
-
-
Feng, S.1
Wang, F.2
Matsubara, A.3
Kan, M.4
McKeehan, W.L.5
-
117
-
-
0035253320
-
Alternative splicing of fibroblast growth factor receptors in human prostate cancer
-
Kwabi-Addo, B., Ropiquet, F., Giri, D., & Ittmann, M. (2001). Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate, 46, 163-172.
-
(2001)
Prostate
, vol.46
, pp. 163-172
-
-
Kwabi-Addo, B.1
Ropiquet, F.2
Giri, D.3
Ittmann, M.4
-
118
-
-
0033835133
-
An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein
-
Carstens, R. P., Wagner, E. J., & Garcia-Blanco, M. A. (2000). An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Molecular and Cellular Biology, 20, 7388-7400.
-
(2000)
Molecular and Cellular Biology
, vol.20
, pp. 7388-7400
-
-
Carstens, R.P.1
Wagner, E.J.2
Garcia-Blanco, M.A.3
-
119
-
-
32044467372
-
Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice
-
DOI 10.1128/MCB.26.4.1209-1222.2006
-
Baraniak, A. P., Chen, J. R., & Garcia-Blanco, M. A. (2006). Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Molecular and Cellular Biology, 26, 1209-1222. (Pubitemid 43202550)
-
(2006)
Molecular and Cellular Biology
, vol.26
, Issue.4
, pp. 1209-1222
-
-
Baraniak, A.P.1
Chen, J.R.2
Garcia-Blanco, M.A.3
-
120
-
-
61649087689
-
ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing
-
Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., & Carstens, R. P. (2009). ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Molecular Cell, 33, 591-601.
-
(2009)
Molecular Cell
, vol.33
, pp. 591-601
-
-
Warzecha, C.C.1
Sato, T.K.2
Nabet, B.3
Hogenesch, J.B.4
Carstens, R.P.5
-
121
-
-
80052322960
-
An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype
-
Shapiro, I. M., Cheng, A. W., Flytzanis, N. C., Balsamo, M., Condeelis, J. S., Oktay, M. H., Burge, C. B., & Gertler, F. B. (2011). An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genetics, 7, e1002218.
-
(2011)
PLoS Genetics
, vol.7
-
-
Shapiro, I.M.1
Cheng, A.W.2
Flytzanis, N.C.3
Balsamo, M.4
Condeelis, J.S.5
Oktay, M.H.6
Burge, C.B.7
Gertler, F.B.8
-
122
-
-
36649025928
-
Inducible FGFR-1 Activation Leads to Irreversible Prostate Adenocarcinoma and an Epithelial-to-Mesenchymal Transition
-
DOI 10.1016/j.ccr.2007.11.004, PII S1535610807003352
-
Acevedo, V. D., Gangula, R. D., Freeman, K. W., Li, R., Zhang, Y., Wang, F., Ayala, G. E., Peterson, L. E., Ittmann, M., & Spencer, D. M. (2007). Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell, 12, 559-571. (Pubitemid 350199071)
-
(2007)
Cancer Cell
, vol.12
, Issue.6
, pp. 559-571
-
-
Acevedo, V.D.1
Gangula, R.D.2
Freeman, K.W.3
Li, R.4
Zhang, Y.5
Wang, F.6
Ayala, G.E.7
Peterson, L.E.8
Ittmann, M.9
Spencer, D.M.10
-
123
-
-
84865444188
-
Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF
-
Bao, B., Ahmad, A., Kong, D., Ali, S., Azmi, A. S., Li, Y., Banerjee, S., Padhye, S., & Sarkar, F. H. (2012). Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and
-
(2012)
PLoS One
, vol.7
-
-
Bao, B.1
Ahmad, A.2
Kong, D.3
Ali, S.4
Azmi, A.S.5
Li, Y.6
Banerjee, S.7
Padhye, S.8
Sarkar, F.H.9
-
125
-
-
79958201891
-
Knockdown of beta-catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1alpha
-
Zhao, J. H., Luo, Y., Jiang, Y. G., He, D. L., & Wu, C. T. (2011). Knockdown of beta-catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1alpha. Cancer Investigation, 29, 377-382.
-
(2011)
Cancer Investigation
, vol.29
, pp. 377-382
-
-
Zhao, J.H.1
Luo, Y.2
Jiang, Y.G.3
He, D.L.4
Wu, C.T.5
-
126
-
-
33744498615
-
Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells
-
Luo, Y., He, D. L., Ning, L., Shen, S. L., Li, L., & Li, X. (2006). Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells. Chinese Medical Journal, 119, 713-718. (Pubitemid 43796824)
-
(2006)
Chinese Medical Journal
, vol.119
, Issue.9
, pp. 713-718
-
-
Luo, Y.1
He, D.-L.2
Ning, L.3
Shen, S.-L.4
Li, L.5
Li, X.6
-
127
-
-
40249113328
-
Direct regulation of TWIST by HIF-1alpha promotes metastasis
-
Yang, M. H., Wu, M. Z., Chiou, S. H., Chen, P. M., Chang, S. Y., Liu, C. J., Teng, S. C., & Wu, K. J. (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nature Cell Biology, 10, 295-305.
-
(2008)
Nature Cell Biology
, vol.10
, pp. 295-305
-
-
Yang, M.H.1
Wu, M.Z.2
Chiou, S.H.3
Chen, P.M.4
Chang, S.Y.5
Liu, C.J.6
Teng, S.C.7
Wu, K.J.8
-
128
-
-
67349114001
-
Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition
-
Sun, S., Ning, X., Zhang, Y., Lu, Y., Nie, Y., Han, S., Liu, L., Du, R., Xia, L., He, L., & Fan, D. (2009). Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney International, 75, 1278-1287.
-
(2009)
Kidney International
, vol.75
, pp. 1278-1287
-
-
Sun, S.1
Ning, X.2
Zhang, Y.3
Lu, Y.4
Nie, Y.5
Han, S.6
Liu, L.7
Du, R.8
Xia, L.9
He, L.10
Fan, D.11
-
129
-
-
79551709511
-
Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma
-
Song, X., Wang, H., Logsdon, C. D., Rashid, A., Fleming, J. B., Abbruzzese, J. L., Gomez, H. F., & Evans, D. B. (2011). Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer, 117, 734-743.
-
(2011)
Cancer
, vol.117
, pp. 734-743
-
-
Song, X.1
Wang, H.2
Logsdon, C.D.3
Rashid, A.4
Fleming, J.B.5
Abbruzzese, J.L.6
Gomez, H.F.7
Evans, D.B.8
-
130
-
-
77249096023
-
Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer
-
Mudduluru, G., Vajkoczy, P., & Allgayer, H. (2010). Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer. Molecular Cancer Research, 8, 159-169.
-
(2010)
Molecular Cancer Research
, vol.8
, pp. 159-169
-
-
Mudduluru, G.1
Vajkoczy, P.2
Allgayer, H.3
-
131
-
-
70449449665
-
Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma
-
Gustafsson, A., Bostrom, A. K., Ljungberg, B., Axelson, H., & Dahlback, B. (2009). Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma. PLoS One, 4, e7575.
-
(2009)
PLoS One
, vol.4
-
-
Gustafsson, A.1
Bostrom, A.K.2
Ljungberg, B.3
Axelson, H.4
Dahlback, B.5
-
132
-
-
75749115996
-
Axl is an essential epithelial-to-mesenchymal transitioninduced regulator of breast cancer metastasis and patient survival
-
Gjerdrum, C., Tiron, C., Hoiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B. T., Micklem, D. R., Akslen, L. A., Glackin, C., & Lorens, J. B. (2010). Axl is an essential epithelial-to-mesenchymal transitioninduced regulator of breast cancer metastasis and patient survival. Proceedings of the National Academy of Sciences of the United States of America, 107, 1124-1129.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 1124-1129
-
-
Gjerdrum, C.1
Tiron, C.2
Hoiby, T.3
Stefansson, I.4
Haugen, H.5
Sandal, T.6
Collett, K.7
Li, S.8
McCormack, E.9
Gjertsen, B.T.10
Micklem, D.R.11
Akslen, L.A.12
Glackin, C.13
Lorens, J.B.14
-
133
-
-
33645821049
-
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
-
Vajkoczy, P., Knyazev, P., Kunkel, A., Capelle, H. H., Behrndt, S., von Tengg-Kobligk, H., Kiessling, F., Eichelsbacher, U., Essig, M., Read, T. A., Erber, R., & Ullrich, A. (2006). Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proceedings of the National Academy of Sciences of the United States of America, 103, 5799-5804.
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, pp. 5799-5804
-
-
Vajkoczy, P.1
Knyazev, P.2
Kunkel, A.3
Capelle, H.H.4
Behrndt, S.5
Von Tengg-Kobligk, H.6
Kiessling, F.7
Eichelsbacher, U.8
Essig, M.9
Read, T.A.10
Erber, R.11
Ullrich, A.12
-
134
-
-
78549245919
-
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma
-
Hector, A., Montgomery, E. A., Karikari, C., Canto, M., Dunbar, K. B., Wang, J. S., Feldmann, G., Hong, S. M., Haffner, M. C., Meeker, A. K., Holland, S. J., Yu, J., Heckrodt, T. J., Zhang, J., Ding, P., Goff, D., Singh, R., Roa, J. C., Marimuthu, A., Riggins, G. J., Eshleman, J. R., Nelkin, B. D., Pandey, A., & Maitra, A. (2010). The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma. Cancer Biology & Therapy, 10, 1009-1018.
-
(2010)
Cancer Biology & Therapy
, vol.10
, pp. 1009-1018
-
-
Hector, A.1
Montgomery, E.A.2
Karikari, C.3
Canto, M.4
Dunbar, K.B.5
Wang, J.S.6
Feldmann, G.7
Hong, S.M.8
Haffner, M.C.9
Meeker, A.K.10
Holland, S.J.11
Yu, J.12
Heckrodt, T.J.13
Zhang, J.14
Ding, P.15
Goff, D.16
Singh, R.17
Roa, J.C.18
Marimuthu, A.19
Riggins, G.J.20
Eshleman, J.R.21
Nelkin, B.D.22
Pandey, A.23
Maitra, A.24
more..
-
135
-
-
85046914648
-
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target
-
Koorstra, J. B., Karikari, C. A., Feldmann, G., Bisht, S., Rojas, P. L., Offerhaus, G. J., Alvarez, H., & Maitra, A. (2009). The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. Cancer Biology & Therapy, 8, 618-626.
-
(2009)
Cancer Biology & Therapy
, vol.8
, pp. 618-626
-
-
Koorstra, J.B.1
Karikari, C.A.2
Feldmann, G.3
Bisht, S.4
Rojas, P.L.5
Offerhaus, G.J.6
Alvarez, H.7
Maitra, A.8
-
136
-
-
68049096311
-
Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival
-
Gustafsson, A., Martuszewska, D., Johansson, M., Ekman, C., Hafizi, S., Ljungberg, B., & Dahlback, B. (2009). Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Clinical Cancer Research, 15, 4742-4749.
-
(2009)
Clinical Cancer Research
, vol.15
, pp. 4742-4749
-
-
Gustafsson, A.1
Martuszewska, D.2
Johansson, M.3
Ekman, C.4
Hafizi, S.5
Ljungberg, B.6
Dahlback, B.7
-
137
-
-
40949156351
-
AXL is a potential target for therapeutic intervention in breast cancer progression
-
DOI 10.1158/0008-5472.CAN-07-2661
-
Zhang, Y. X., Knyazev, P. G., Cheburkin, Y. V., Sharma, K., Knyazev, Y. P., Orfi, L., Szabadkai, I., Daub, H., Keri, G., & Ullrich, A. (2008). AXL is a potential target for therapeutic intervention in breast cancer progression. Cancer Research, 68, 1905-1915. (Pubitemid 351416577)
-
(2008)
Cancer Research
, vol.68
, Issue.6
, pp. 1905-1915
-
-
Zhang, Y.-X.1
Knyazev, P.G.2
Cheburkin, Y.V.3
Sharma, K.4
Knyazev, Y.P.5
Orfi, L.6
Szabadkai, I.7
Daub, H.8
Keri, G.9
Ullrich, A.10
-
138
-
-
40749123639
-
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
-
DOI 10.1158/1078-0432.CCR-07-0862
-
Hutterer, M., Knyazev, P., Abate, A., Reschke, M., Maier, H., Stefanova, N., Knyazeva, T., Barbieri, V., Reindl, M., Muigg, A., Kostron, H., Stockhammer, G., & Ullrich, A. (2008). Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clinical Cancer Research, 14, 130-138. (Pubitemid 351377987)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.1
, pp. 130-138
-
-
Hutterer, M.1
Knyazev, P.2
Abate, A.3
Reschke, M.4
Maier, H.5
Stefanova, N.6
Knyazeva, T.7
Barbieri, V.8
Reindl, M.9
Muigg, A.10
Kostron, H.11
Stockhammer, G.12
Ullrich, A.13
-
139
-
-
84862555781
-
Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer
-
Mishra, A., Wang, J., Shiozawa, Y., McGee, S., Kim, J., Jung, Y., Joseph, J., Berry, J. E., Havens, A., Pienta, K. J., & Taichman, R. S. (2012). Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. Molecular Cancer Research, 10, 703-712.
-
(2012)
Molecular Cancer Research
, vol.10
, pp. 703-712
-
-
Mishra, A.1
Wang, J.2
Shiozawa, Y.3
McGee, S.4
Kim, J.5
Jung, Y.6
Joseph, J.7
Berry, J.E.8
Havens, A.9
Pienta, K.J.10
Taichman, R.S.11
-
141
-
-
0035902141
-
The microenvironment of the tumour-host interface
-
Liotta, L. A., & Kohn, E. C. (2001). The microenvironment of the tumour-host interface. Nature, 411, 375-379.
-
(2001)
Nature
, vol.411
, pp. 375-379
-
-
Liotta, L.A.1
Kohn, E.C.2
-
142
-
-
10344234761
-
Molecular insights into prostate cancer progression: The missing link of tumor microenvironment
-
DOI 10.1097/01.ju.0000141582.15218.10
-
Chung, L. W., Baseman, A., Assikis, V., & Zhau, H. E. (2005). Molecular insights into prostate cancer progression: The missing link of tumor microenvironment. The Journal of Urology, 173, 10-20. (Pubitemid 39627663)
-
(2005)
Journal of Urology
, vol.173
, Issue.1
, pp. 10-20
-
-
Chung, L.W.K.1
Baseman, A.2
Assikis, V.3
Zhau, H.E.4
-
143
-
-
33847719299
-
Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts
-
Kaminski, A., Hahne, J. C., Haddouti el, M., Florin, A., Wellmann, A., & Wernert, N. (2006). Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. International Journal of Molecular Medicine, 18, 941-950.
-
(2006)
International Journal of Molecular Medicine
, vol.18
, pp. 941-950
-
-
Kaminski, A.1
Hahne, J.C.2
Haddouti El, M.3
Florin, A.4
Wellmann, A.5
Wernert, N.6
-
144
-
-
79957532451
-
Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness
-
Giannoni, E., Bianchini, F., Calorini, L., & Chiarugi, P. (2011). Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxidants & Redox Signaling, 14, 2361-2371.
-
(2011)
Antioxidants & Redox Signaling
, vol.14
, pp. 2361-2371
-
-
Giannoni, E.1
Bianchini, F.2
Calorini, L.3
Chiarugi, P.4
-
145
-
-
0029802488
-
Transforming growth factor beta1-induced apoptosis in human ovarian carcinoma cells: Protection by the antioxidant N-acetylcysteine and bcl-2
-
Lafon, C., Mathieu, C., Guerrin, M., Pierre, O., Vidal, S., & Valette, A. (1996). Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant Nacetylcysteine and bcl-2. Cell Growth & Differentiation, 7, 1095-1104. (Pubitemid 26360721)
-
(1996)
Cell Growth and Differentiation
, vol.7
, Issue.8
, pp. 1095-1104
-
-
Lafon, C.1
Mathieu, C.2
Guerrin, M.3
Pierre, O.4
Vidal, S.5
Valette, A.6
-
146
-
-
20544437490
-
Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells
-
DOI 10.1681/ASN.2004050425
-
Rhyu, D. Y., Yang, Y., Ha, H., Lee, G. T., Song, J. S., Uh, S. T., & Lee, H. B. (2005). Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Journal of the American Society of Nephrology, 16, 667-675. (Pubitemid 41725103)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.3
, pp. 667-675
-
-
Rhyu, D.Y.1
Yang, Y.2
Ha, H.3
Lee, G.T.4
Song, J.S.5
Uh, S.-T.6
Lee, H.B.7
-
147
-
-
21844432918
-
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
-
DOI 10.1038/nature03688
-
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Nieto, M. A., Werb, Z., & Bissell, M. J. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-127. (Pubitemid 40966197)
-
(2005)
Nature
, vol.436
, Issue.7047
, pp. 123-127
-
-
Radisky, D.C.1
Levy, D.D.2
Littlepage, L.E.3
Liu, H.4
Nelson, C.M.5
Fata, J.E.6
Leake, D.7
Godden, E.L.8
Albertson, D.G.9
Nieto, M.A.10
Werb, Z.11
Bissell, M.J.12
-
148
-
-
78650898629
-
Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells
-
Barnett, P., Arnold, R. S., Mezencev, R., Chung, L. W., Zayzafoon, M., & Odero-Marah, V. (2011). Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochemical and Biophysical Research Communications, 404, 34-39.
-
(2011)
Biochemical and Biophysical Research Communications
, vol.404
, pp. 34-39
-
-
Barnett, P.1
Arnold, R.S.2
Mezencev, R.3
Chung, L.W.4
Zayzafoon, M.5
Odero-Marah, V.6
-
149
-
-
84902535394
-
Reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells
-
doi:10.1002/mc.22014
-
Das, T. P., Suman, S., & Damodaran, C. (2013). Reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells. Molecular Carcinogenesis. doi:10.1002/mc.22014.
-
(2013)
Molecular Carcinogenesis
-
-
Das, T.P.1
Suman, S.2
Damodaran, C.3
-
150
-
-
84868633053
-
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
-
Sun, Y., Campisi, J., Higano, C., Beer, T. M., Porter, P., Coleman, I., True, L., & Nelson, P. S. (2012). Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature Medicine, 18, 1359-1368.
-
(2012)
Nature Medicine
, vol.18
, pp. 1359-1368
-
-
Sun, Y.1
Campisi, J.2
Higano, C.3
Beer, T.M.4
Porter, P.5
Coleman, I.6
True, L.7
Nelson, P.S.8
-
151
-
-
67449110963
-
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models
-
Zhang, Y., Daquinag, A., Traktuev, D. O., Amaya-Manzanares, F., Simmons, P. J., March, K. L., Pasqualini, R., Arap, W., & Kolonin, M. G. (2009). White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Research, 69, 5259-5266.
-
(2009)
Cancer Research
, vol.69
, pp. 5259-5266
-
-
Zhang, Y.1
Daquinag, A.2
Traktuev, D.O.3
Amaya-Manzanares, F.4
Simmons, P.J.5
March, K.L.6
Pasqualini, R.7
Arap, W.8
Kolonin, M.G.9
-
152
-
-
84856013044
-
Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance
-
Chao, Y., Wu, Q., Shepard, C., & Wells, A. (2012). Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clinical & Experimental Metastasis, 29, 39-50.
-
(2012)
Clinical & Experimental Metastasis
, vol.29
, pp. 39-50
-
-
Chao, Y.1
Wu, Q.2
Shepard, C.3
Wells, A.4
-
153
-
-
34247217230
-
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
-
DOI 10.1038/sj.bjc.6603700, PII 6603700
-
Yates, C. C., Shepard, C. R., Stolz, D. B., & Wells, A. (2007). Coculturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. British Journal of Cancer, 96, 1246-1252. (Pubitemid 46625074)
-
(2007)
British Journal of Cancer
, vol.96
, Issue.8
, pp. 1246-1252
-
-
Yates, C.C.1
Shepard, C.R.2
Stolz, D.B.3
Wells, A.4
-
154
-
-
77956811470
-
Tumor-stromal interactions influence radiation sensitivity in epithelialversus mesenchymal-like prostate cancer cells
-
doi:10.1155/2010/232831
-
S. Josson, S. Sharp, S. Y. Sung, P. A. Johnstone, R. Aneja, R. Wang, M. Gururajan, T. Turner, L. W. Chung, and C. Yates (2010) Tumor-stromal interactions influence radiation sensitivity in epithelialversus mesenchymal-like prostate cancer cells. Journal of Oncology, 2010. doi:10.1155/2010/232831.
-
(2010)
Journal of Oncology
, vol.2010
-
-
Josson, S.1
Sharp, S.2
Sung, S.Y.3
Johnstone, P.A.4
Aneja, R.5
Wang, R.6
Gururajan, M.7
Turner, T.8
Chung, L.W.9
Yates, C.10
-
155
-
-
33749025816
-
Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostrate tumors reveals unexpected epithelial mesenchymal plasticity
-
DOI 10.1073/pnas.0603090103
-
Oltean, S., Sorg, B. S., Albrecht, T., Bonano, V. I., Brazas, R. M., Dewhirst, M. W., & Garcia-Blanco, M. A. (2006). Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proceedings of the National Academy of Sciences of the United States of America, 103, 14116-14121. (Pubitemid 44452989)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.38
, pp. 14116-14121
-
-
Oltean, S.1
Sorg, B.S.2
Albrecht, T.3
Bonano, V.I.4
Brazas, R.M.5
Dewhirst, M.W.6
Garcia-Blanco, M.A.7
-
156
-
-
84864722456
-
Histone deacetylase inhibitors in the treatment of cancer: Overview and perspectives
-
Giannini, G., Cabri, W., Fattorusso, C., & Rodriquez, M. (2012). Histone deacetylase inhibitors in the treatment of cancer: Overview and perspectives. Future Medicinal Chemistry, 4, 1439-1460.
-
(2012)
Future Medicinal Chemistry
, vol.4
, pp. 1439-1460
-
-
Giannini, G.1
Cabri, W.2
Fattorusso, C.3
Rodriquez, M.4
-
157
-
-
84866419172
-
Histone deacetylase inhibitors induce epithelial-tomesenchymal transition in prostate cancer cells
-
Kong, D., Ahmad, A., Bao, B., Li, Y., Banerjee, S., & Sarkar, F. H. (2012). Histone deacetylase inhibitors induce epithelial-tomesenchymal transition in prostate cancer cells. PLoS One, 7, e45045.
-
(2012)
PLoS One
, vol.7
-
-
Kong, D.1
Ahmad, A.2
Bao, B.3
Li, Y.4
Banerjee, S.5
Sarkar, F.H.6
-
158
-
-
72249110437
-
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium
-
Bradley, D., Rathkopf, D., Dunn, R., Stadler, W. M., Liu, G., Smith, D. C., Pili, R., Zwiebel, J., Scher, H., & Hussain, M. (2009). Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium. Cancer, 115, 5541-5549.
-
(2009)
Cancer
, vol.115
, pp. 5541-5549
-
-
Bradley, D.1
Rathkopf, D.2
Dunn, R.3
Stadler, W.M.4
Liu, G.5
Smith, D.C.6
Pili, R.7
Zwiebel, J.8
Scher, H.9
Hussain, M.10
-
159
-
-
78650978001
-
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14)multiplemyeloma cells
-
Martinez-Garcia, E., Popovic, R., Min, D. J., Sweet, S. M., Thomas, P. M., Zamdborg, L., Heffner, A., Will, C., Lamy, L., Staudt, L. M., Levens, D. L., Kelleher, N. L., & Licht, J. D. (2011). The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14)multiplemyeloma cells. Blood, 117, 211-220.
-
(2011)
Blood
, vol.117
, pp. 211-220
-
-
Martinez-Garcia, E.1
Popovic, R.2
Min, D.J.3
Sweet, S.M.4
Thomas, P.M.5
Zamdborg, L.6
Heffner, A.7
Will, C.8
Lamy, L.9
Staudt, L.M.10
Levens, D.L.11
Kelleher, N.L.12
Licht, J.D.13
-
160
-
-
79958845131
-
MMSET is highly expressed and associated with aggressiveness in neuroblastoma
-
Hudlebusch, H. R., Skotte, J., Santoni-Rugiu, E., Zimling, Z. G., Lees, M. J., Simon, R., Sauter, G., Rota, R., De Ioris, M. A., Quarto, M., Johansen, J. V., Jorgensen, M., Rechnitzer, C., Maroun, L. L., Schroder, H., Petersen, B. L., & Helin, K. (2011). MMSET is highly expressed and associated with aggressiveness in neuroblastoma. Cancer Research, 71, 4226-4235.
-
(2011)
Cancer Research
, vol.71
, pp. 4226-4235
-
-
Hudlebusch, H.R.1
Skotte, J.2
Santoni-Rugiu, E.3
Zimling, Z.G.4
Lees, M.J.5
Simon, R.6
Sauter, G.7
Rota, R.8
De Ioris, M.A.9
Quarto, M.10
Johansen, J.V.11
Jorgensen, M.12
Rechnitzer, C.13
Maroun, L.L.14
Schroder, H.15
Petersen, B.L.16
Helin, K.17
-
161
-
-
58949087354
-
MMSET is overexpressed in cancers: Link with tumor aggressiveness
-
Kassambara, A., Klein, B., & Moreaux, J. (2009). MMSET is overexpressed in cancers: link with tumor aggressiveness. Biochemical and Biophysical Research Communications, 379, 840-845.
-
(2009)
Biochemical and Biophysical Research Communications
, vol.379
, pp. 840-845
-
-
Kassambara, A.1
Klein, B.2
Moreaux, J.3
-
162
-
-
84879414983
-
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer
-
Ezponda, T., Popovic, R., Shah, M. Y., Martinez-Garcia, E., Zheng, Y., Min, D. J., Will, C., Neri, A., Kelleher, N. L., Yu, J., & Licht, J. D. (2013). The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene, 32, 2882-2890.
-
(2013)
Oncogene
, vol.32
, pp. 2882-2890
-
-
Ezponda, T.1
Popovic, R.2
Shah, M.Y.3
Martinez-Garcia, E.4
Zheng, Y.5
Min, D.J.6
Will, C.7
Neri, A.8
Kelleher, N.L.9
Yu, J.10
Licht, J.D.11
-
163
-
-
0036709074
-
Human Sir2 and the "silencing" of p53 activity
-
Smith, J. (2002). Human Sir2 and the "silencing" of p53 activity. Trends in Cell Biology, 12, 404-406.
-
(2002)
Trends in Cell Biology
, vol.12
, pp. 404-406
-
-
Smith, J.1
-
164
-
-
4143050290
-
The interaction between FOXO and SIRT1: Tipping the balance towards survival
-
Giannakou, M. E., & Partridge, L. (2004). The interaction between FOXO and SIRT1: Tipping the balance towards survival. Trends in Cell Biology, 14, 408-412.
-
(2004)
Trends in Cell Biology
, vol.14
, pp. 408-412
-
-
Giannakou, M.E.1
Partridge, L.2
-
165
-
-
84867901275
-
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
-
Byles, V., Zhu, L., Lovaas, J. D., Chmilewski, L. K., Wang, J., Faller, D. V., & Dai, Y. (2012). SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene, 31, 4619-4629.
-
(2012)
Oncogene
, vol.31
, pp. 4619-4629
-
-
Byles, V.1
Zhu, L.2
Lovaas, J.D.3
Chmilewski, L.K.4
Wang, J.5
Faller, D.V.6
Dai, Y.7
-
166
-
-
57649124289
-
Repression of Ecadherin by the polycomb group protein EZH2 in cancer
-
Cao, Q., Yu, J., Dhanasekaran, S. M., Kim, J. H., Mani, R. S., Tomlins, S. A., Mehra, R., Laxman, B., Cao, X., Kleer, C. G., Varambally, S., & Chinnaiyan, A. M. (2008). Repression of Ecadherin by the polycomb group protein EZH2 in cancer. Oncogene, 27, 7274-7284.
-
(2008)
Oncogene
, vol.27
, pp. 7274-7284
-
-
Cao, Q.1
Yu, J.2
Dhanasekaran, S.M.3
Kim, J.H.4
Mani, R.S.5
Tomlins, S.A.6
Mehra, R.7
Laxman, B.8
Cao, X.9
Kleer, C.G.10
Varambally, S.11
Chinnaiyan, A.M.12
-
167
-
-
55249111607
-
Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone
-
Saha, B., Kaur, P., Tsao-Wei, D., Naritoku, W. Y., Groshen, S., Datar, R. H., Jones, L. W., & Imam, S. A. (2008). Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate, 68, 1681-1688.
-
(2008)
Prostate
, vol.68
, pp. 1681-1688
-
-
Saha, B.1
Kaur, P.2
Tsao-Wei, D.3
Naritoku, W.Y.4
Groshen, S.5
Datar, R.H.6
Jones, L.W.7
Imam, S.A.8
-
169
-
-
0347444723
-
MicroRNAs: Genomics, biogenesis, mechanism, and function
-
Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
-
(2004)
Cell
, vol.116
, pp. 281-297
-
-
Bartel, D.P.1
-
170
-
-
84861802693
-
MicroRNAs: Critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression
-
Bullock, M. D., Sayan, A. E., Packham, G. K., & Mirnezami, A. H. (2012). MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biology of the Cell, 104, 3-12.
-
(2012)
Biology of the Cell
, vol.104
, pp. 3-12
-
-
Bullock, M.D.1
Sayan, A.E.2
Packham, G.K.3
Mirnezami, A.H.4
-
171
-
-
84872608167
-
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms
-
Liu, Y. N., Yin, J. J., Abou-Kheir, W., Hynes, P. G., Casey, O. M., Fang, L., Yi, M., Stephens, R. M., Seng, V., Sheppard-Tillman, H., Martin, P., & Kelly, K. (2013). MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene, 32, 296-306.
-
(2013)
Oncogene
, vol.32
, pp. 296-306
-
-
Liu, Y.N.1
Yin, J.J.2
Abou-Kheir, W.3
Hynes, P.G.4
Casey, O.M.5
Fang, L.6
Yi, M.7
Stephens, R.M.8
Seng, V.9
Sheppard-Tillman, H.10
Martin, P.11
Kelly, K.12
-
172
-
-
69249156944
-
miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells
-
Kong, D., Li, Y., Wang, Z., Banerjee, S., Ahmad, A., Kim, H. R., & Sarkar, F. H. (2009). miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27, 1712-1721.
-
(2009)
Stem Cells
, vol.27
, pp. 1712-1721
-
-
Kong, D.1
Li, Y.2
Wang, Z.3
Banerjee, S.4
Ahmad, A.5
Kim, H.R.6
Sarkar, F.H.7
-
173
-
-
77957902732
-
Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells
-
Kong, D., Banerjee, S., Ahmad, A., Li, Y., Wang, Z., Sethi, S., & Sarkar, F. H. (2010). Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One, 5, e12445.
-
(2010)
PLoS One
, vol.5
-
-
Kong, D.1
Banerjee, S.2
Ahmad, A.3
Li, Y.4
Wang, Z.5
Sethi, S.6
Sarkar, F.H.7
-
174
-
-
84869160169
-
Epithelial-tomesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205
-
Puhr, M., Hoefer, J., Schafer, G., Erb, H. H., Oh, S. J., Klocker, H., Heidegger, I., Neuwirt, H., & Culig, Z. (2012). Epithelial-tomesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205. The American Journal of Pathology, 181, 2188-2201.
-
(2012)
The American Journal of Pathology
, vol.181
, pp. 2188-2201
-
-
Puhr, M.1
Hoefer, J.2
Schafer, G.3
Erb, H.H.4
Oh, S.J.5
Klocker, H.6
Heidegger, I.7
Neuwirt, H.8
Culig, Z.9
-
175
-
-
84878016403
-
MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells
-
Qu, Y., Li, W. C., Hellem, M. R., Rostad, K., Popa, M., McCormack, E., Oyan, A. M., Kalland, K. H., & Ke, X. S. (2013). MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. International Journal of Cancer, 133, 544-555.
-
(2013)
International Journal of Cancer
, vol.133
, pp. 544-555
-
-
Qu, Y.1
Li, W.C.2
Hellem, M.R.3
Rostad, K.4
Popa, M.5
McCormack, E.6
Oyan, A.M.7
Kalland, K.H.8
Ke, X.S.9
-
176
-
-
84876122205
-
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial - Mesenchymal transition
-
Coppola, V., Musumeci, M., Patrizii, M., Cannistraci, A., Addario, A., Maugeri-Sacca, M., Biffoni, M., Francescangeli, F., Cordenonsi, M., Piccolo, S., Memeo, L., Pagliuca, A., Muto, G., Zeuner, A., De Maria, R., & Bonci, D. (2013). BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial - mesenchymal transition. Oncogene, 32, 1843-1853.
-
(2013)
Oncogene
, vol.32
, pp. 1843-1853
-
-
Coppola, V.1
Musumeci, M.2
Patrizii, M.3
Cannistraci, A.4
Addario, A.5
Maugeri-Sacca, M.6
Biffoni, M.7
Francescangeli, F.8
Cordenonsi, M.9
Piccolo, S.10
Memeo, L.11
Pagliuca, A.12
Muto, G.13
Zeuner, A.14
De Maria, R.15
Bonci, D.16
-
177
-
-
84876312244
-
Plasma miRNAs as biomarkers to identify patients with castration-resistantmetastatic prostate cancer
-
Watahiki, A., Macfarlane, R. J., Gleave, M. E., Crea, F., Wang, Y., Helgason, C. D., & Chi, K. N. (2013). Plasma miRNAs as biomarkers to identify patients with castration-resistantmetastatic prostate cancer. International Journal of Molecular Sciences, 14, 7757-7770.
-
(2013)
International Journal of Molecular Sciences
, vol.14
, pp. 7757-7770
-
-
Watahiki, A.1
Macfarlane, R.J.2
Gleave, M.E.3
Crea, F.4
Wang, Y.5
Helgason, C.D.6
Chi, K.N.7
-
178
-
-
84862645250
-
miRNA-29b suppresses prostate cancer metastasis by regulating epithelial - Mesenchymal transition signaling
-
Ru, P., Steele, R., Newhall, P., Phillips, N. J., Toth, K., & Ray, R. B. (2012). miRNA-29b suppresses prostate cancer metastasis by regulating epithelial - mesenchymal transition signaling. Molecular Cancer Therapeutics, 11, 1166-1173.
-
(2012)
Molecular Cancer Therapeutics
, vol.11
, pp. 1166-1173
-
-
Ru, P.1
Steele, R.2
Newhall, P.3
Phillips, N.J.4
Toth, K.5
Ray, R.B.6
-
179
-
-
84866546174
-
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer
-
Tucci, P., Agostini, M., Grespi, F., Markert, E. K., Terrinoni, A., Vousden, K. H., Muller, P. A., Dotsch, V., Kehrloesser, S., Sayan, B. S., Giaccone, G., Lowe, S. W., Takahashi, N., Vandenabeele, P., Knight, R. A., Levine, A. J., & Melino, G. (2012). Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 109, 15312-15317.
-
(2012)
Proceedings of the National Academy of Sciences of the United States of America
, vol.109
, pp. 15312-15317
-
-
Tucci, P.1
Agostini, M.2
Grespi, F.3
Markert, E.K.4
Terrinoni, A.5
Vousden, K.H.6
Muller, P.A.7
Dotsch, V.8
Kehrloesser, S.9
Sayan, B.S.10
Giaccone, G.11
Lowe, S.W.12
Takahashi, N.13
Vandenabeele, P.14
Knight, R.A.15
Levine, A.J.16
Melino, G.17
-
180
-
-
0033594891
-
Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention
-
Zi, X., & Agarwal, R. (1999). Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention. Proceedings of the National Academy of Sciences of the United States of America, 96, 7490-7495.
-
(1999)
Proceedings of the National Academy of Sciences of the United States of America
, vol.96
, pp. 7490-7495
-
-
Zi, X.1
Agarwal, R.2
-
181
-
-
0036847718
-
2-M arrest, and apoptosis
-
Tyagi, A. K., Singh, R. P., Agarwal, C., Chan, D. C., & Agarwal, R. (2002). Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Clinical Cancer Research, 8, 3512-3519. (Pubitemid 35340729)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.11
, pp. 3512-3519
-
-
Tyagi, A.K.1
Singh, R.P.2
Agarwal, C.3
Chan, D.C.F.4
Agarwal, R.5
-
182
-
-
0043025262
-
Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death
-
DOI 10.1002/ijc.11299
-
Dhanalakshmi, S., Agarwal, P., Glode, L. M., & Agarwal, R. (2003). Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death. International Journal of Cancer, 106, 699-705. (Pubitemid 36993393)
-
(2003)
International Journal of Cancer
, vol.106
, Issue.5
, pp. 699-705
-
-
Dhanalakshmi, S.1
Agarwal, P.2
Michael, G.L.3
Agarwal, R.4
-
183
-
-
33947195450
-
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells
-
DOI 10.1002/ijc.22465
-
Flaig, T. W., Su, L. J., Harrison, G., Agarwal, R., & Glode, L. M. (2007). Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. International Journal of Cancer, 120, 2028-2033. (Pubitemid 46418384)
-
(2007)
International Journal of Cancer
, vol.120
, Issue.9
, pp. 2028-2033
-
-
Flaig, T.W.1
Su, L.-J.2
Harrison, G.3
Agarwal, R.4
Glode, L.M.5
-
184
-
-
0036843213
-
Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells
-
DOI 10.1002/pros.10146
-
Tyagi, A., Bhatia, N., Condon, M. S., Bosland, M. C., Agarwal, C., & Agarwal, R. (2002). Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Prostate, 53, 211-217. (Pubitemid 35266181)
-
(2002)
Prostate
, vol.53
, Issue.3
, pp. 211-217
-
-
Tyagi, A.1
Bhatia, N.2
Condon, M.S.3
Bosland, M.C.4
Agarwal, C.5
Agarwal, R.6
-
185
-
-
34547829030
-
Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells
-
DOI 10.1093/carcin/bgm042
-
Agarwal, C., Tyagi, A., Kaur, M., & Agarwal, R. (2007). Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis, 28, 1463-1470. (Pubitemid 47243538)
-
(2007)
Carcinogenesis
, vol.28
, Issue.7
, pp. 1463-1470
-
-
Agarwal, C.1
Tyagi, A.2
Kaur, M.3
Agarwal, R.4
-
186
-
-
0034812087
-
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP
-
Zhu, W., Zhang, J. S., & Young, C. Y. (2001). Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis, 22, 1399-1403. (Pubitemid 32898696)
-
(2001)
Carcinogenesis
, vol.22
, Issue.9
, pp. 1399-1403
-
-
Zhu, W.1
Zhang, J.-S.2
Young, C.Y.F.3
-
187
-
-
47549097718
-
Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line
-
Mokhtari, M. J., Motamed, N., & Shokrgozar, M. A. (2008). Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line. Cell Biology International, 32, 888-892.
-
(2008)
Cell Biology International
, vol.32
, pp. 888-892
-
-
Mokhtari, M.J.1
Motamed, N.2
Shokrgozar, M.A.3
-
188
-
-
68349113541
-
Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression
-
Wu, K. J., Zeng, J., Zhu, G. D., Zhang, L. L., Zhang, D., Li, L., Fan, J. H., Wang, X. Y., & He, D. L. (2009). Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Acta Pharmacologica Sinica, 30, 1162-1168.
-
(2009)
Acta Pharmacologica Sinica
, vol.30
, pp. 1162-1168
-
-
Wu, K.J.1
Zeng, J.2
Zhu, G.D.3
Zhang, L.L.4
Zhang, D.5
Li, L.6
Fan, J.H.7
Wang, X.Y.8
He, D.L.9
-
189
-
-
77951742472
-
Silibinin reverses epithelial-tomesenchymal transition in metastatic prostate cancer cells by targeting transcription factors
-
Wu, K., Zeng, J., Li, L., Fan, J., Zhang, D., Xue, Y., Zhu, G., Yang, L., Wang, X., & He, D. (2010). Silibinin reverses epithelial-tomesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. Oncology Reports, 23, 1545-1552.
-
(2010)
Oncology Reports
, vol.23
, pp. 1545-1552
-
-
Wu, K.1
Zeng, J.2
Li, L.3
Fan, J.4
Zhang, D.5
Xue, Y.6
Zhu, G.7
Yang, L.8
Wang, X.9
He, D.10
-
190
-
-
70349928634
-
Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells
-
Jung, H. J., Park, J. W., Lee, J. S., Lee, S. R., Jang, B. C., Suh, S. I., Suh, M. H., & Baek, W. K. (2009). Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells. Biochemical and Biophysical Research Communications, 390, 71-76.
-
(2009)
Biochemical and Biophysical Research Communications
, vol.390
, pp. 71-76
-
-
Jung, H.J.1
Park, J.W.2
Lee, J.S.3
Lee, S.R.4
Jang, B.C.5
Suh, S.I.6
Suh, M.H.7
Baek, W.K.8
-
191
-
-
51349125301
-
A novel anti-cancer effect of genistein: Reversal of epithelial mesenchymal transition in prostate cancer cells
-
Zhang, L. L., Li, L., Wu, D. P., Fan, J. H., Li, X., Wu, K. J., Wang, X. Y., & He, D. L. (2008). A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells. Acta Pharmacologica Sinica, 29, 1060-1068.
-
(2008)
Acta Pharmacologica Sinica
, vol.29
, pp. 1060-1068
-
-
Zhang, L.L.1
Li, L.2
Wu, D.P.3
Fan, J.H.4
Li, X.5
Wu, K.J.6
Wang, X.Y.7
He, D.L.8
-
192
-
-
84861807248
-
Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway
-
Zhang, L., Li, L., Jiao, M., Wu, D., Wu, K., Li, X., Zhu, G., Yang, L., Wang, X., Hsieh, J. T., & He, D. (2012). Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway. Cancer Letters, 323, 48-57.
-
(2012)
Cancer Letters
, vol.323
, pp. 48-57
-
-
Zhang, L.1
Li, L.2
Jiao, M.3
Wu, D.4
Wu, K.5
Li, X.6
Zhu, G.7
Yang, L.8
Wang, X.9
Hsieh, J.T.10
He, D.11
-
193
-
-
84874878684
-
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer
-
Chiyomaru, T., Yamamura, S., Fukuhara, S., Hidaka, H., Majid, S., Saini, S., Arora, S., Deng, G., Shahryari, V., Chang, I., Tanaka, Y., Tabatabai, Z. L., Enokida, H., Seki, N., Nakagawa, M., & Dahiya, R. (2013). Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One, 8, e58929.
-
(2013)
PLoS One
, vol.8
-
-
Chiyomaru, T.1
Yamamura, S.2
Fukuhara, S.3
Hidaka, H.4
Majid, S.5
Saini, S.6
Arora, S.7
Deng, G.8
Shahryari, V.9
Chang, I.10
Tanaka, Y.11
Tabatabai, Z.L.12
Enokida, H.13
Seki, N.14
Nakagawa, M.15
Dahiya, R.16
-
194
-
-
70349973076
-
Inhibition of epithelial to mesenchymal transition inmetastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: Pivotal roles of Snail repression and RKIP induction
-
Baritaki, S., Chapman, A., Yeung, K., Spandidos, D. A., Palladino, M., & Bonavida, B. (2009). Inhibition of epithelial to mesenchymal transition inmetastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene, 28, 3573-3585.
-
(2009)
Oncogene
, vol.28
, pp. 3573-3585
-
-
Baritaki, S.1
Chapman, A.2
Yeung, K.3
Spandidos, D.A.4
Palladino, M.5
Bonavida, B.6
-
195
-
-
51449085561
-
Generation of breast cancer stem cells through epithelial-mesenchymal transition
-
Morel, A. P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 3, e2888.
-
(2008)
PLoS One
, vol.3
-
-
Morel, A.P.1
Lievre, M.2
Thomas, C.3
Hinkal, G.4
Ansieau, S.5
Puisieux, A.6
-
196
-
-
84879647438
-
Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells
-
Lan, L., Luo, Y., Cui, D., Shi, B. Y., Deng, W., Huo, L. L., Chen, H. L., Zhang, G. Y., & Deng, L. L. (2013). Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. International Journal of Oncology, 43, 113-120.
-
(2013)
International Journal of Oncology
, vol.43
, pp. 113-120
-
-
Lan, L.1
Luo, Y.2
Cui, D.3
Shi, B.Y.4
Deng, W.5
Huo, L.L.6
Chen, H.L.7
Zhang, G.Y.8
Deng, L.L.9
-
197
-
-
67349156673
-
Invasive prostate cancer cells are tumor initiating cells that have a stem celllike genomic signature
-
Klarmann, G. J., Hurt, E. M., Mathews, L. A., Zhang, X., Duhagon, M. A., Mistree, T., Thomas, S. B., & Farrar, W. L. (2009). Invasive prostate cancer cells are tumor initiating cells that have a stem celllike genomic signature. Clinical & Experimental Metastasis, 26, 433-446.
-
(2009)
Clinical & Experimental Metastasis
, vol.26
, pp. 433-446
-
-
Klarmann, G.J.1
Hurt, E.M.2
Mathews, L.A.3
Zhang, X.4
Duhagon, M.A.5
Mistree, T.6
Thomas, S.B.7
Farrar, W.L.8
-
198
-
-
84861903355
-
ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features
-
Albino, D., Longoni, N., Curti, L., Mello-Grand, M., Pinton, S., Civenni, G., Thalmann, G., D'Ambrosio, G., Sarti, M., Sessa, F., Chiorino, G., Catapano, C. V., & Carbone, G. M. (2012). ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Research, 72, 2889-2900.
-
(2012)
Cancer Research
, vol.72
, pp. 2889-2900
-
-
Albino, D.1
Longoni, N.2
Curti, L.3
Mello-Grand, M.4
Pinton, S.5
Civenni, G.6
Thalmann, G.7
D'Ambrosio, G.8
Sarti, M.9
Sessa, F.10
Chiorino, G.11
Catapano, C.V.12
Carbone, G.M.13
-
199
-
-
78649669021
-
Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation
-
Lukacs, R. U., Memarzadeh, S., Wu, H., & Witte, O. N. (2010). Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell, 7, 682-693.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 682-693
-
-
Lukacs, R.U.1
Memarzadeh, S.2
Wu, H.3
Witte, O.N.4
-
200
-
-
84866021276
-
Suppression of acquired docetaxel resistance in prostate cancer through depletion of Notch- and Hedgehog-dependent tumor-initiating cells
-
Domingo-Domenech, J., Vidal, S. J., Rodriguez-Bravo, V., Castillo-Martin, M., Quinn, S. A., Rodriguez-Barrueco, R., Bonal, D. M., Charytonowicz, E., Gladoun, N., de la Iglesia-Vicente, J., Petrylak, D. P., Benson, M. C., Silva, J. M., & Cordon-Cardo, C. (2012). Suppression of acquired docetaxel resistance in prostate cancer through depletion of Notch- and Hedgehog-dependent tumor-initiating cells. Cancer Cell, 22, 373-388.
-
(2012)
Cancer Cell
, vol.22
, pp. 373-388
-
-
Domingo-Domenech, J.1
Vidal, S.J.2
Rodriguez-Bravo, V.3
Castillo-Martin, M.4
Quinn, S.A.5
Rodriguez-Barrueco, R.6
Bonal, D.M.7
Charytonowicz, E.8
Gladoun, N.9
De La Iglesia-Vicente, J.10
Petrylak, D.P.11
Benson, M.C.12
Silva, J.M.13
Cordon-Cardo, C.14
-
201
-
-
77950503213
-
Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells
-
Bae, K. M., Su, Z., Frye, C., McClellan, S., Allan, R. W., Andrejewski, J. T., Kelley, V., Jorgensen, M., Steindler, D. A., Vieweg, J., & Siemann, D. W. (2010). Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. The Journal of Urology, 183, 2045-2053.
-
(2010)
The Journal of Urology
, vol.183
, pp. 2045-2053
-
-
Bae, K.M.1
Su, Z.2
Frye, C.3
McClellan, S.4
Allan, R.W.5
Andrejewski, J.T.6
Kelley, V.7
Jorgensen, M.8
Steindler, D.A.9
Vieweg, J.10
Siemann, D.W.11
-
202
-
-
80052829163
-
Drug-tolerant cancer cells show reduced tumor-initiating capacity: Depletion of CD44 cells and evidence for epigenetic mechanisms
-
Yan, H., Chen, X., Zhang, Q., Qin, J., Li, H., Liu, C., Calhoun-Davis, T., Coletta, L. D., Klostergaard, J., Fokt, I., Skora, S., Priebe, W., Bi, Y., & Tang, D. G. (2011). Drug-tolerant cancer cells show reduced tumor-initiating capacity: Depletion of CD44 cells and evidence for epigenetic mechanisms. PLoS One, 6, e24397.
-
(2011)
PLoS One
, vol.6
-
-
Yan, H.1
Chen, X.2
Zhang, Q.3
Qin, J.4
Li, H.5
Liu, C.6
Calhoun-Davis, T.7
Coletta, L.D.8
Klostergaard, J.9
Fokt, I.10
Skora, S.11
Priebe, W.12
Bi, Y.13
Tang, D.G.14
-
203
-
-
79952771880
-
Revisiting the concept of cancer stem cells in prostate cancer
-
Wang, Z. A., & Shen, M. M. (2011). Revisiting the concept of cancer stem cells in prostate cancer. Oncogene, 30, 1261-1271.
-
(2011)
Oncogene
, vol.30
, pp. 1261-1271
-
-
Wang, Z.A.1
Shen, M.M.2
-
204
-
-
68749099671
-
Identification of selective inhibitors of cancer stem cells by high-throughput screening
-
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 138, 645-659.
-
(2009)
Cell
, vol.138
, pp. 645-659
-
-
Gupta, P.B.1
Onder, T.T.2
Jiang, G.3
Tao, K.4
Kuperwasser, C.5
Weinberg, R.A.6
Lander, E.S.7
-
205
-
-
6044259206
-
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
-
DOI 10.1158/1078-0432.CCR-04-0378
-
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G., Uhr, J. W., & Terstappen, L. W. (2004). Tumor cells circulate in the peripheral blood of allmajor carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research, 10, 6897-6904. (Pubitemid 39383039)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.20
, pp. 6897-6904
-
-
Allard, W.J.1
Matera, J.2
Miller, M.C.3
Repollet, M.4
Connelly, M.C.5
Rao, C.6
Tibbe, A.G.J.7
Uhr, J.W.8
Terstappen, L.W.M.M.9
-
206
-
-
4143094988
-
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
-
DOI 10.1056/NEJMoa040766
-
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W., & Hayes, D. F. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England Journal of Medicine, 351, 781-791. (Pubitemid 39095313)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.8
, pp. 781-791
-
-
Cristofanilli, M.1
Budd, G.T.2
Ellis, M.J.3
Stopeck, A.4
Matera, J.5
Miller, M.C.6
Reuben, J.M.7
Doyle, G.V.8
Allard, W.J.9
Terstappen, L.W.M.M.10
Hayes, D.F.11
-
207
-
-
58149165081
-
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
-
de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W., Pienta, K. J., & Raghavan, D. (2008). Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clinical Cancer Research, 14, 6302-6309.
-
(2008)
Clinical Cancer Research
, vol.14
, pp. 6302-6309
-
-
De Bono, J.S.1
Scher, H.I.2
Montgomery, R.B.3
Parker, C.4
Miller, M.C.5
Tissing, H.6
Doyle, G.V.7
Terstappen, L.W.8
Pienta, K.J.9
Raghavan, D.10
-
208
-
-
49249130844
-
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
-
Cohen, S. J., Punt, C. J., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., Doyle, G. V., Tissing, H., Terstappen, L. W., & Meropol, N. J. (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Journal of Clinical Oncology, 26, 3213-3221.
-
(2008)
Journal of Clinical Oncology
, vol.26
, pp. 3213-3221
-
-
Cohen, S.J.1
Punt, C.J.2
Iannotti, N.3
Saidman, B.H.4
Sabbath, K.D.5
Gabrail, N.Y.6
Picus, J.7
Morse, M.8
Mitchell, E.9
Miller, M.C.10
Doyle, G.V.11
Tissing, H.12
Terstappen, L.W.13
Meropol, N.J.14
-
209
-
-
84873374248
-
Circulating tumor cells as prognostic markers in neuroendocrine tumors
-
Khan, M. S., Kirkwood, A., Tsigani, T., Garcia-Hernandez, J., Hartley, J. A., Caplin, M. E., & Meyer, T. (2013). Circulating tumor cells as prognostic markers in neuroendocrine tumors. Journal of Clinical Oncology, 31, 365-372.
-
(2013)
Journal of Clinical Oncology
, vol.31
, pp. 365-372
-
-
Khan, M.S.1
Kirkwood, A.2
Tsigani, T.3
Garcia-Hernandez, J.4
Hartley, J.A.5
Caplin, M.E.6
Meyer, T.7
-
210
-
-
80053085982
-
End points and outcomes in castration-resistant prostate cancer: From clinical trials to clinical practice
-
Scher, H. I., Morris, M. J., Basch, E., & Heller, G. (2011). End points and outcomes in castration-resistant prostate cancer: From clinical trials to clinical practice. Journal of Clinical Oncology, 29, 3695-3704.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 3695-3704
-
-
Scher, H.I.1
Morris, M.J.2
Basch, E.3
Heller, G.4
-
211
-
-
80055001749
-
Detection of circulating tumour cells with a hybrid (epithelial/ mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
-
Lecharpentier, A., Vielh, P., Perez-Moreno, P., Planchard, D., Soria, J. C., & Farace, F. (2011). Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. British Journal of Cancer, 105, 1338-1341.
-
(2011)
British Journal of Cancer
, vol.105
, pp. 1338-1341
-
-
Lecharpentier, A.1
Vielh, P.2
Perez-Moreno, P.3
Planchard, D.4
Soria, J.C.5
Farace, F.6
-
212
-
-
84858335921
-
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches
-
Krebs, M. G., Hou, J. M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., Ranson, M., Blackhall, F. H., & Dive, C. (2012). Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. Journal of Thoracic Oncology, 7, 306-315.
-
(2012)
Journal of Thoracic Oncology
, vol.7
, pp. 306-315
-
-
Krebs, M.G.1
Hou, J.M.2
Sloane, R.3
Lancashire, L.4
Priest, L.5
Nonaka, D.6
Ward, T.H.7
Backen, A.8
Clack, G.9
Hughes, A.10
Ranson, M.11
Blackhall, F.H.12
Dive, C.13
-
213
-
-
84868014773
-
Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis
-
Bellizzi, A., Sebastian, S., Ceglia, P., Centonze, M., Divella, R., Manzillo, E. F., Azzariti, A., Silvestris, N., Montemurro, S., Caliandro, C., De Luca, R., Cicero, G., Rizzo, S., Russo, A., Quaranta, M., Simone, G., & Paradiso, A. (2013). Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis. Journal of Cellular Physiology, 228, 408-415.
-
(2013)
Journal of Cellular Physiology
, vol.228
, pp. 408-415
-
-
Bellizzi, A.1
Sebastian, S.2
Ceglia, P.3
Centonze, M.4
Divella, R.5
Manzillo, E.F.6
Azzariti, A.7
Silvestris, N.8
Montemurro, S.9
Caliandro, C.10
De Luca, R.11
Cicero, G.12
Rizzo, S.13
Russo, A.14
Quaranta, M.15
Simone, G.16
Paradiso, A.17
-
214
-
-
84861712713
-
Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
-
Barriere, G., Riouallon, A., Renaudie, J., Tartary, M., & Rigaud, M. (2012). Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis. BMC Cancer, 12, 114.
-
(2012)
BMC Cancer
, vol.12
, pp. 114
-
-
Barriere, G.1
Riouallon, A.2
Renaudie, J.3
Tartary, M.4
Rigaud, M.5
-
215
-
-
58549113573
-
Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells
-
Sieuwerts, A. M., Kraan, J., Bolt, J., van der Spoel, P., Elstrodt, F., Schutte, M., Martens, J. W., Gratama, J. W., Sleijfer, S., & Foekens, J. A. (2009). Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. Journal of the National Cancer Institute, 101, 61-66.
-
(2009)
Journal of the National Cancer Institute
, vol.101
, pp. 61-66
-
-
Sieuwerts, A.M.1
Kraan, J.2
Bolt, J.3
Van Der Spoel, P.4
Elstrodt, F.5
Schutte, M.6
Martens, J.W.7
Gratama, J.W.8
Sleijfer, S.9
Foekens, J.A.10
-
216
-
-
82955187028
-
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
-
Raimondi, C., Gradilone, A., Naso, G., Vincenzi, B., Petracca, A., Nicolazzo, C., Palazzo, A., Saltarelli, R., Spremberg, F., Cortesi, E., & Gazzaniga, P. (2011). Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Research and Treatment, 130, 449-455.
-
(2011)
Breast Cancer Research and Treatment
, vol.130
, pp. 449-455
-
-
Raimondi, C.1
Gradilone, A.2
Naso, G.3
Vincenzi, B.4
Petracca, A.5
Nicolazzo, C.6
Palazzo, A.7
Saltarelli, R.8
Spremberg, F.9
Cortesi, E.10
Gazzaniga, P.11
-
217
-
-
84875970076
-
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells
-
Ozkumur, E., Shah, A. M., Ciciliano, J. C., Emmink, B. L., Miyamoto, D. T., Brachtel, E., Yu, M., Chen, P. I., Morgan, B., Trautwein, J., Kimura, A., Sengupta, S., Stott, S. L., Karabacak, N. M., Barber, T. A., Walsh, J. R., Smith, K., Spuhler, P. S., Sullivan, J. P., Lee, R. J., Ting, D. T., Luo, X., Shaw, A. T., Bardia, A., Sequist, L. V., Louis, D. N., Maheswaran, S., Kapur, R., Haber, D. A., & Toner, M. (2013). "Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells,". Science Translational Medicine, 5, 179ra47.
-
(2013)
Science Translational Medicine
, vol.5
-
-
Ozkumur, E.1
Shah, A.M.2
Ciciliano, J.C.3
Emmink, B.L.4
Miyamoto, D.T.5
Brachtel, E.6
Yu, M.7
Chen, P.I.8
Morgan, B.9
Trautwein, J.10
Kimura, A.11
Sengupta, S.12
Stott, S.L.13
Karabacak, N.M.14
Barber, T.A.15
Walsh, J.R.16
Smith, K.17
Spuhler, P.S.18
Sullivan, J.P.19
Lee, R.J.20
Ting, D.T.21
Luo, X.22
Shaw, A.T.23
Bardia, A.24
Sequist, L.V.25
Louis, D.N.26
Maheswaran, S.27
Kapur, R.28
Haber, D.A.29
Toner, M.30
more..
-
218
-
-
79960435644
-
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response
-
Ryan, C. J., Shah, S., Efstathiou, E., Smith, M. R., Taplin, M. E., Bubley, G. J., Logothetis, C. J., Kheoh, T., Kilian, C., Haqq, C. M., Molina, A., & Small, E. J. (2011). Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response. Clinical Cancer Research, 17, 4854-4861.
-
(2011)
Clinical Cancer Research
, vol.17
, pp. 4854-4861
-
-
Ryan, C.J.1
Shah, S.2
Efstathiou, E.3
Smith, M.R.4
Taplin, M.E.5
Bubley, G.J.6
Logothetis, C.J.7
Kheoh, T.8
Kilian, C.9
Haqq, C.M.10
Molina, A.11
Small, E.J.12
-
219
-
-
84874787799
-
Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial
-
Smith, D. C., Smith, M. R., Sweeney, C., Elfiky, A. A., Logothetis, C., Corn, P. G., Vogelzang, N. J., Small, E. J., Harzstark, A. L., Gordon, M. S., Vaishampayan, U. N., Haas, N. B., Spira, A. I., Lara, P. N., Jr., Lin, C. C., Srinivas, S., Sella, A., Schoffski, P., Scheffold, C., Weitzman, A. L., & Hussain, M. (2013). Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial. Journal of Clinical Oncology, 31, 412-419.
-
(2013)
Journal of Clinical Oncology
, vol.31
, pp. 412-419
-
-
Smith, D.C.1
Smith, M.R.2
Sweeney, C.3
Elfiky, A.A.4
Logothetis, C.5
Corn, P.G.6
Vogelzang, N.J.7
Small, E.J.8
Harzstark, A.L.9
Gordon, M.S.10
Vaishampayan, U.N.11
Haas, N.B.12
Spira, A.I.13
Lara Jr., P.N.14
Lin, C.C.15
Srinivas, S.16
Sella, A.17
Schoffski, P.18
Scheffold, C.19
Weitzman, A.L.20
Hussain, M.21
more..
-
220
-
-
84878961883
-
A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases
-
May 15
-
R. J. Lee, P. J. Saylor, M. D. Michaelson, S. M. Rothenberg, M. E. Smas, D. T. Miyamoto, C. A. Gurski, W. Xie, S. Maheswaran, D. A. Haber, J. G. Goldin, and M. R. Smith, " A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases," Clin Cancer Res, May 15 2013
-
(2013)
Clin Cancer Res
-
-
Lee, R.J.1
Saylor, P.J.2
Michaelson, M.D.3
Rothenberg, S.M.4
Smas, M.E.5
Miyamoto, D.T.6
Gurski, C.A.7
Xie, W.8
Maheswaran, S.9
Haber, D.A.10
Goldin, J.G.11
Smith, M.R.12
-
221
-
-
20444453337
-
Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target
-
DOI 10.1158/0008-5472.CAN-04-3785
-
Kwok, W. K., Ling, M. T., Lee, T. W., Lau, T. C., Zhou, C., Zhang, X., Chua, C. W., Chan, K. W., Chan, F. L., Glackin, C., Wong, Y. C., & Wang, X. (2005). Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Research, 65, 5153-5162. (Pubitemid 40827324)
-
(2005)
Cancer Research
, vol.65
, Issue.12
, pp. 5153-5162
-
-
Kwok, W.K.1
Ling, M.-T.2
Lee, T.-W.3
Lau, T.C.M.4
Zhou, C.5
Zhang, X.6
Chua, C.W.7
Chan, K.W.8
Chan, F.L.9
Glackin, C.10
Wong, Y.-C.11
Wang, X.12
-
222
-
-
78650223132
-
Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis
-
Sethi, S., Macoska, J., Chen, W., & Sarkar, F. H. (2010). Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. American Journal of Translational Research, 3, 90-99.
-
(2010)
American Journal of Translational Research
, vol.3
, pp. 90-99
-
-
Sethi, S.1
Macoska, J.2
Chen, W.3
Sarkar, F.H.4
-
223
-
-
37249030356
-
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer
-
DOI 10.1158/1078-0432.CCR-07-1263
-
Gravdal, K., Halvorsen, O. J., Haukaas, S. A., & Akslen, L. A. (2007). A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clinical Cancer Research, 13, 7003-7011. (Pubitemid 350276881)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.23
, pp. 7003-7011
-
-
Gravdal, K.1
Halvorsen, O.J.2
Haukaas, S.A.3
Akslen, L.A.4
-
224
-
-
84871617813
-
Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: Significance in clinicopathological outcomes following radical prostatectomy
-
Behnsawy, H. M., Miyake, H., Harada, K., & Fujisawa, M. (2013). Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: Significance in clinicopathological outcomes following radical prostatectomy. BJU International, 111, 30-37.
-
(2013)
BJU International
, vol.111
, pp. 30-37
-
-
Behnsawy, H.M.1
Miyake, H.2
Harada, K.3
Fujisawa, M.4
-
225
-
-
27344451557
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
-
DOI 10.1126/science.1117679
-
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X. W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J. E., Shah, R. B., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2005). Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 310, 644-648. (Pubitemid 41528150)
-
(2005)
Science
, vol.310
, Issue.5748
, pp. 644-648
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Perner, S.3
Dhanasekaran, S.M.4
Mehra, R.5
Sun, X.-W.6
Varambally, S.7
Cao, X.8
Tchinda, J.9
Kuefer, R.10
Lee, C.11
Montie, J.E.12
Shah, R.B.13
Pienta, K.J.14
Rubin, M.A.15
Chinnaiyan, A.M.16
-
226
-
-
34547642493
-
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
-
DOI 10.1038/nature06024, PII NATURE06024
-
Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B., Yu, J., Wang, L., Montie, J. E., Rubin, M. A., Pienta, K. J., Roulston, D., Shah, R. B., Varambally, S., Mehra, R., & Chinnaiyan, A. M. (2007). Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature, 448, 595-599. (Pubitemid 47206938)
-
(2007)
Nature
, vol.448
, Issue.7153
, pp. 595-599
-
-
Tomlins, S.A.1
Laxman, B.2
Dhanasekaran, S.M.3
Helgeson, B.E.4
Cao, X.5
Morris, D.S.6
Menon, A.7
Jing, X.8
Cao, Q.9
Han, B.10
Yu, J.11
Wang, L.12
Montie, J.E.13
Rubin, M.A.14
Pienta, K.J.15
Roulston, D.16
Shah, R.B.17
Varambally, S.18
Mehra, R.19
Chinnaiyan, A.M.20
more..
-
227
-
-
77956290679
-
FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells
-
Gupta, S., Iljin, K., Sara, H., Mpindi, J. P., Mirtti, T., Vainio, P., Rantala, J., Alanen, K., Nees, M., & Kallioniemi, O. (2010). FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Research, 70, 6735-6745.
-
(2010)
Cancer Research
, vol.70
, pp. 6735-6745
-
-
Gupta, S.1
Iljin, K.2
Sara, H.3
Mpindi, J.P.4
Mirtti, T.5
Vainio, P.6
Rantala, J.7
Alanen, K.8
Nees, M.9
Kallioniemi, O.10
-
228
-
-
79959829839
-
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model
-
Leshem, O., Madar, S., Kogan-Sakin, I., Kamer, I., Goldstein, I., Brosh, R., Cohen, Y., Jacob-Hirsch, J., Ehrlich, M., Ben-Sasson, S., Goldfinger, N., Loewenthal, R., Gazit, E., Rotter, V., & Berger, R. (2011). TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. PLoS One, 6, e21650.
-
(2011)
PLoS One
, vol.6
-
-
Leshem, O.1
Madar, S.2
Kogan-Sakin, I.3
Kamer, I.4
Goldstein, I.5
Brosh, R.6
Cohen, Y.7
Jacob-Hirsch, J.8
Ehrlich, M.9
Ben-Sasson, S.10
Goldfinger, N.11
Loewenthal, R.12
Gazit, E.13
Rotter, V.14
Berger, R.15
-
229
-
-
34248510706
-
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
-
DOI 10.1038/sj.onc.1210237, PII 1210237
-
Demichelis, F., Fall, K., Perner, S., Andren, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J. M., Pawitan, Y., Lee, C., Adami, H. O., Mucci, L. A., Kantoff, P. W., Andersson, S. O., Chinnaiyan, A. M., Johansson, J. E., & Rubin, M. A. (2007). TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene, 26, 4596-4599. (Pubitemid 47037039)
-
(2007)
Oncogene
, vol.26
, Issue.31
, pp. 4596-4599
-
-
Demichelis, F.1
Fall, K.2
Perner, S.3
Andren, O.4
Schmidt, F.5
Setlur, S.R.6
Hoshida, Y.7
Mosquera, J.-M.8
Pawitan, Y.9
Lee, C.10
Adami, H.-O.11
Mucci, L.A.12
Kantoff, P.W.13
Andersson, S.-O.14
Chinnaiyan, A.M.15
Johansson, J.-E.16
Rubin, M.A.17
-
230
-
-
37049015104
-
Expression of the TMPRSS2: ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
-
DOI 10.1038/sj.bjc.6604054, PII 6604054
-
Nam, R. K., Sugar, L., Yang, W., Srivastava, S., Klotz, L. H., Yang, L. Y., Stanimirovic, A., Encioiu, E., Neill, M., Loblaw, D. A., Trachtenberg, J., Narod, S. A., & Seth, A. (2007). Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. British Journal of Cancer, 97, 1690-1695. (Pubitemid 350249347)
-
(2007)
British Journal of Cancer
, vol.97
, Issue.12
, pp. 1690-1695
-
-
Nam, R.K.1
Sugar, L.2
Yang, W.3
Srivastava, S.4
Klotz, L.H.5
Yang, L.-Y.6
Stanimirovic, A.7
Encioiu, E.8
Neill, M.9
Loblaw, D.A.10
Trachtenberg, J.11
Narod, S.A.12
Seth, A.13
-
231
-
-
38049123346
-
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
-
Attard, G., Clark, J., Ambroisine, L., Fisher, G., Kovacs, G., Flohr, P., Berney, D., Foster, C. S., Fletcher, A., Gerald, W. L., Moller, H., Reuter, V., De Bono, J. S., Scardino, P., Cuzick, J., & Cooper, C. S. (2008). Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene, 27, 253- 263.
-
(2008)
Oncogene
, vol.27
, pp. 253-263
-
-
Attard, G.1
Clark, J.2
Ambroisine, L.3
Fisher, G.4
Kovacs, G.5
Flohr, P.6
Berney, D.7
Foster, C.S.8
Fletcher, A.9
Gerald, W.L.10
Moller, H.11
Reuter, V.12
De Bono, J.S.13
Scardino, P.14
Cuzick, J.15
Cooper, C.S.16
-
232
-
-
84866172302
-
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: A cohort study and meta-analysis
-
Pettersson, A., Graff, R. E., Bauer, S. R., Pitt, M. J., Lis, R. T., Stack, E. C., Martin, N. E., Kunz, L., Penney, K. L., Ligon, A. H., Suppan, C., Flavin, R., Sesso, H. D., Rider, J. R., Sweeney, C., Stampfer, M. J., Fiorentino, M., Kantoff, P. W., Sanda, M. G., Giovannucci, E. L., Ding, E. L., Loda, M., & Mucci, L. A. (2012). The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: A cohort study and meta-analysis. Cancer Epidemiology, Biomarkers & Prevention, 21, 1497-1509.
-
(2012)
Cancer Epidemiology, Biomarkers & Prevention
, vol.21
, pp. 1497-1509
-
-
Pettersson, A.1
Graff, R.E.2
Bauer, S.R.3
Pitt, M.J.4
Lis, R.T.5
Stack, E.C.6
Martin, N.E.7
Kunz, L.8
Penney, K.L.9
Ligon, A.H.10
Suppan, C.11
Flavin, R.12
Sesso, H.D.13
Rider, J.R.14
Sweeney, C.15
Stampfer, M.J.16
Fiorentino, M.17
Kantoff, P.W.18
Sanda, M.G.19
Giovannucci, E.L.20
Ding, E.L.21
Loda, M.22
Mucci, L.A.23
more..
-
233
-
-
84876948946
-
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
-
Chen, C. L., Mahalingam, D., Osmulski, P., Jadhav, R. R., Wang, C. M., Leach, R. J., Chang, T. C., Weitman, S. D., Kumar, A. P., Sun, L., Gaczynska, M. E., Thompson, I. M., & Huang, T. H. (2013). Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate, 73, 813-826.
-
(2013)
Prostate
, vol.73
, pp. 813-826
-
-
Chen, C.L.1
Mahalingam, D.2
Osmulski, P.3
Jadhav, R.R.4
Wang, C.M.5
Leach, R.J.6
Chang, T.C.7
Weitman, S.D.8
Kumar, A.P.9
Sun, L.10
Gaczynska, M.E.11
Thompson, I.M.12
Huang, T.H.13
-
234
-
-
77953576511
-
N-Cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer
-
Jennbacken, K., Tesan, T., Wang, W., Gustavsson, H., Damber, J. E., & Welen, K. (2010). N-Cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer. Endocrine-Related Cancer, 17, 469-479.
-
(2010)
Endocrine-Related Cancer
, vol.17
, pp. 469-479
-
-
Jennbacken, K.1
Tesan, T.2
Wang, W.3
Gustavsson, H.4
Damber, J.E.5
Welen, K.6
-
235
-
-
78650016651
-
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
-
Tanaka, H., Kono, E., Tran, C. P., Miyazaki, H., Yamashiro, J., Shimomura, T., Fazli, L., Wada, R., Huang, J., Vessella, R. L., An, J., Horvath, S., Gleave, M., Rettig, M. B., Wainberg, Z. A., & Reiter, R. E. (2010). Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nature Medicine, 16, 1414-1420.
-
(2010)
Nature Medicine
, vol.16
, pp. 1414-1420
-
-
Tanaka, H.1
Kono, E.2
Tran, C.P.3
Miyazaki, H.4
Yamashiro, J.5
Shimomura, T.6
Fazli, L.7
Wada, R.8
Huang, J.9
Vessella, R.L.10
An, J.11
Horvath, S.12
Gleave, M.13
Rettig, M.B.14
Wainberg, Z.A.15
Reiter, R.E.16
-
236
-
-
80052475968
-
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases
-
Putzke, A. P., Ventura, A. P., Bailey, A. M., Akture, C., Opoku-Ansah, J., Celiktas, M., Hwang, M. S., Darling, D. S., Coleman, I. M., Nelson, P. S., Nguyen, H. M., Corey, E., Tewari, M., Morrissey, C., Vessella, R. L., & Knudsen, B. S. (2011). Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. The American Journal of Pathology, 179, 400-410.
-
(2011)
The American Journal of Pathology
, vol.179
, pp. 400-410
-
-
Putzke, A.P.1
Ventura, A.P.2
Bailey, A.M.3
Akture, C.4
Opoku-Ansah, J.5
Celiktas, M.6
Hwang, M.S.7
Darling, D.S.8
Coleman, I.M.9
Nelson, P.S.10
Nguyen, H.M.11
Corey, E.12
Tewari, M.13
Morrissey, C.14
Vessella, R.L.15
Knudsen, B.S.16
-
237
-
-
70449526719
-
Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility
-
Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S., & Sahai, E. (2009). Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nature Cell Biology, 11, 1287-1296.
-
(2009)
Nature Cell Biology
, vol.11
, pp. 1287-1296
-
-
Giampieri, S.1
Manning, C.2
Hooper, S.3
Jones, L.4
Hill, C.S.5
Sahai, E.6
-
238
-
-
75149172293
-
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival
-
Armstrong, A. J., Tannock, I. F., de Wit, R., George, D. J., Eisenberger, M., & Halabi, S. (2010). The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival. European Journal of Cancer, 46, 517-525.
-
(2010)
European Journal of Cancer
, vol.46
, pp. 517-525
-
-
Armstrong, A.J.1
Tannock, I.F.2
De Wit, R.3
George, D.J.4
Eisenberger, M.5
Halabi, S.6
-
239
-
-
84860642507
-
The PSA(-/lo) prostate cancer cell population harbors selfrenewing long-term tumor-propagating cells that resist castration
-
Qin, J., Liu, X., Laffin, B., Chen, X., Choy, G., Jeter, C. R., Calhoun-Davis, T., Li, H., Palapattu, G. S., Pang, S., Lin, K., Huang, J., Ivanov, I., Li, W., Suraneni, M. V., & Tang, D. G. (2012). The PSA(-/lo) prostate cancer cell population harbors selfrenewing long-term tumor-propagating cells that resist castration. Cell Stem Cell, 10, 556-569.
-
(2012)
Cell Stem Cell
, vol.10
, pp. 556-569
-
-
Qin, J.1
Liu, X.2
Laffin, B.3
Chen, X.4
Choy, G.5
Jeter, C.R.6
Calhoun-Davis, T.7
Li, H.8
Palapattu, G.S.9
Pang, S.10
Lin, K.11
Huang, J.12
Ivanov, I.13
Li, W.14
Suraneni, M.V.15
Tang, D.G.16
-
240
-
-
79960125220
-
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
-
Kottke, T., Errington, F., Pulido, J., Galivo, F., Thompson, J., Wongthida, P., Diaz, R. M., Chong, H., Ilett, E., Chester, J., Pandha, H., Harrington, K., Selby, P., Melcher, A., & Vile, R. (2011). Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures
-
(2011)
Nature Medicine
, vol.17
, pp. 854-859
-
-
Kottke, T.1
Errington, F.2
Pulido, J.3
Galivo, F.4
Thompson, J.5
Wongthida, P.6
Diaz, R.M.7
Chong, H.8
Ilett, E.9
Chester, J.10
Pandha, H.11
Harrington, K.12
Selby, P.13
Melcher, A.14
Vile, R.15
-
241
-
-
77955066199
-
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
-
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., Xu, Y., Frohlich, M. W., & Schellhammer, P. F. (2010). Sipuleucel-T immunotherapy for castration-resistant prostate cancer. The New England Journal of Medicine, 363, 411-422.
-
(2010)
The New England Journal of Medicine
, vol.363
, pp. 411-422
-
-
Kantoff, P.W.1
Higano, C.S.2
Shore, N.D.3
Berger, E.R.4
Small, E.J.5
Penson, D.F.6
Redfern, C.H.7
Ferrari, A.C.8
Dreicer, R.9
Sims, R.B.10
Xu, Y.11
Frohlich, M.W.12
Schellhammer, P.F.13
-
242
-
-
77949895922
-
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer
-
Kantoff, P. W., Schuetz, T. J., Blumenstein, B. A., Glode, L. M., Bilhartz, D. L., Wyand, M., Manson, K., Panicali, D. L., Laus, R., Schlom, J., Dahut, W. L., Arlen, P. M., Gulley, J. L., & Godfrey, W. R. (2010). Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology, 28, 1099-1105.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 1099-1105
-
-
Kantoff, P.W.1
Schuetz, T.J.2
Blumenstein, B.A.3
Glode, L.M.4
Bilhartz, D.L.5
Wyand, M.6
Manson, K.7
Panicali, D.L.8
Laus, R.9
Schlom, J.10
Dahut, W.L.11
Arlen, P.M.12
Gulley, J.L.13
Godfrey, W.R.14
-
243
-
-
35948929512
-
Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells
-
Yuan, T. C., Veeramani, S., & Lin, M. F. (2007). Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocrine-Related Cancer, 14, 531-547.
-
(2007)
Endocrine-Related Cancer
, vol.14
, pp. 531-547
-
-
Yuan, T.C.1
Veeramani, S.2
Lin, M.F.3
-
244
-
-
79955975429
-
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer
-
Carver, B. S., Chapinski, C., Wongvipat, J., Hieronymus, H., Chen, Y., Chandarlapaty, S., Arora, V. K., Le, C., Koutcher, J., Scher, H., Scardino, P. T., Rosen, N., & Sawyers, C. L. (2011). Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell, 19, 575-586.
-
(2011)
Cancer Cell
, vol.19
, pp. 575-586
-
-
Carver, B.S.1
Chapinski, C.2
Wongvipat, J.3
Hieronymus, H.4
Chen, Y.5
Chandarlapaty, S.6
Arora, V.K.7
Le, C.8
Koutcher, J.9
Scher, H.10
Scardino, P.T.11
Rosen, N.12
Sawyers, C.L.13
-
245
-
-
84879478480
-
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
-
Bitting, R. L., & Armstrong, A. J. (2013). Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Endocrine-Related Cancer, 20, R83-R99.
-
(2013)
Endocrine-Related Cancer
, vol.20
-
-
Bitting, R.L.1
Armstrong, A.J.2
-
246
-
-
84858424089
-
Converting cancer therapies into cures: Lessons from infectious diseases
-
Glickman, M. S., & Sawyers, C. L. (2012). Converting cancer therapies into cures: lessons from infectious diseases. Cell, 148, 1089-1098.
-
(2012)
Cell
, vol.148
, pp. 1089-1098
-
-
Glickman, M.S.1
Sawyers, C.L.2
-
247
-
-
77955121375
-
Identification of a cell of origin for human prostate cancer
-
Goldstein, A. S., Huang, J., Guo, C., Garraway, I. P., & Witte, O. N. (2010). Identification of a cell of origin for human prostate cancer. Science, 329, 568-571.
-
(2010)
Science
, vol.329
, pp. 568-571
-
-
Goldstein, A.S.1
Huang, J.2
Guo, C.3
Garraway, I.P.4
Witte, O.N.5
-
248
-
-
84877048131
-
Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells
-
Cottard, F., Asmane, I., Erdmann, E., Bergerat, J. P., Kurtz, J. E., & Ceraline, J. (2013). Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells. PLoS One, 8, p. e63466.
-
(2013)
PLoS One
, vol.8
-
-
Cottard, F.1
Asmane, I.2
Erdmann, E.3
Bergerat, J.P.4
Kurtz, J.E.5
Ceraline, J.6
-
249
-
-
84866096019
-
Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug
-
Brennen, W. N., Rosen, D. M., Wang, H., Isaacs, J. T., & Denmeade, S. R. (2012). Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. Journal of the National Cancer Institute, 104, 1320-1334.
-
(2012)
Journal of the National Cancer Institute
, vol.104
, pp. 1320-1334
-
-
Brennen, W.N.1
Rosen, D.M.2
Wang, H.3
Isaacs, J.T.4
Denmeade, S.R.5
-
250
-
-
84862907616
-
Targeting the Hedgehog signaling pathway for cancer therapy
-
Li, Y., Maitah, M. Y., Ahmad, A., Kong, D., Bao, B., & Sarkar, F. H. (2012). Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opinion on Therapeutic Targets, 16, 49-66.
-
(2012)
Expert Opinion on Therapeutic Targets
, vol.16
, pp. 49-66
-
-
Li, Y.1
Maitah, M.Y.2
Ahmad, A.3
Kong, D.4
Bao, B.5
Sarkar, F.H.6
-
251
-
-
84861968011
-
Therapeutic approaches to modulating Notch signaling: Current challenges and future prospects
-
Groth, C., & Fortini, M. E. (2012). Therapeutic approaches to modulating Notch signaling: Current challenges and future prospects. Seminars in Cell & Developmental Biology, 23, 465-472.
-
(2012)
Seminars in Cell & Developmental Biology
, vol.23
, pp. 465-472
-
-
Groth, C.1
Fortini, M.E.2
-
252
-
-
84865787544
-
Molecular pathways: Targeting the TGF-beta pathway for cancer therapy
-
Smith, A. L., Robin, T. P., & Ford, H. L. (2012). Molecular pathways: Targeting the TGF-beta pathway for cancer therapy. Clinical Cancer Research, 18, 4514-4521.
-
(2012)
Clinical Cancer Research
, vol.18
, pp. 4514-4521
-
-
Smith, A.L.1
Robin, T.P.2
Ford, H.L.3
-
253
-
-
84884377857
-
AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancer
-
Liu, G., Sprenger, C., Sun, S., Epilepsia, K. S., Haugk, K., Zhang, X., et al. (2013). AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancer. Neoplasia, 15, pp. 1009-1017.
-
(2013)
Neoplasia
, vol.15
, pp. 1009-1017
-
-
Liu, G.1
Sprenger, C.2
Sun, S.3
Epilepsia, K.S.4
Haugk, K.5
Zhang, X.6
-
254
-
-
84873824523
-
Potential predictive biomarkers for individualizing treatment for men with castrationresistant prostate cancer
-
Bitting, R. L., & Armstrong, A. J. (2013). Potential predictive biomarkers for individualizing treatment for men with castrationresistant prostate cancer. Cancer Journal, 19, 25-33.
-
(2013)
Cancer Journal
, vol.19
, pp. 25-33
-
-
Bitting, R.L.1
Armstrong, A.J.2
-
255
-
-
84863895439
-
Cure models as a useful statistical tool for analyzing survival
-
Othus, M., Barlogie, B., Leblanc, M. L., & Crowley, J. J. (2012). Cure models as a useful statistical tool for analyzing survival. Clinical Cancer Research, 18, 3731-3736.
-
(2012)
Clinical Cancer Research
, vol.18
, pp. 3731-3736
-
-
Othus, M.1
Barlogie, B.2
Leblanc, M.L.3
Crowley, J.J.4
-
256
-
-
84866770294
-
Increased survival with enzalutamide in prostate cancer after chemotherapy
-
Scher, H. I., Fizazi, K., Saad, F., Taplin, M. E., Sternberg, C. N., Miller, K., et al. (2012). Increased survival with enzalutamide in prostate cancer after chemotherapy. The New England Journal of Medicine, 367, 1187-1197.
-
(2012)
The New England Journal of Medicine
, vol.367
, pp. 1187-1197
-
-
Scher, H.I.1
Fizazi, K.2
Saad, F.3
Taplin, M.E.4
Sternberg, C.N.5
Miller, K.6
-
257
-
-
84863230424
-
ARN-509: A novel antiandrogen for prostate cancer treatment
-
Clegg, N. J., Wongvipat, J., Joseph, J. D., Tran, C., Ouk, S., Dilhas, A., Chen, Y., Grillot, K., Bischoff, E. D., Cai, L., Aparicio, A., Dorow, S., Arora, V., Shao, G., Qian, J., Zhao, H., Yang, G., Cao, C., Sensintaffar, J., Wasielewska, T., Herbert, M. R., Bonnefous, C., Darimont, B., Scher, H. I., Smith-Jones, P., Klang, M., Smith, N. D., De Stanchina, E., Wu, N., Ouerfelli, O., Rix, P. J., Heyman, R. A., Jung, M. E., Sawyers, C. L., & Hager, J. H. (2012). ARN-509: a novel antiandrogen for prostate cancer treatment. Cancer Research, 72, 1494-1503.
-
(2012)
Cancer Research
, vol.72
, pp. 1494-1503
-
-
Clegg, N.J.1
Wongvipat, J.2
Joseph, J.D.3
Tran, C.4
Ouk, S.5
Dilhas, A.6
Chen, Y.7
Grillot, K.8
Bischoff, E.D.9
Cai, L.10
Aparicio, A.11
Dorow, S.12
Arora, V.13
Shao, G.14
Qian, J.15
Zhao, H.16
Yang, G.17
Cao, C.18
Sensintaffar, J.19
Wasielewska, T.20
Herbert, M.R.21
Bonnefous, C.22
Darimont, B.23
Scher, H.I.24
Smith-Jones, P.25
Klang, M.26
Smith, N.D.27
De Stanchina, E.28
Wu, N.29
Ouerfelli, O.30
Rix, P.J.31
Heyman, R.A.32
Jung, M.E.33
Sawyers, C.L.34
Hager, J.H.35
more..
-
258
-
-
84870908111
-
Phase I clinical trial of galeterone (TOK-001), a multifunctional antiandrogen and CYP17 inhibitor in castration resistant prostate cancer
-
abstr 4665
-
Montgomery, R. B., Eisenberger, M. A., Rettig, M., Chu, F., Pili, R., Stephenson, J., Vogelzang, N. J., Morrison, J., & Taplin, M. (2012). Phase I clinical trial of galeterone (TOK-001), a multifunctional antiandrogen and CYP17 inhibitor in castration resistant prostate cancer. Journal of Clinical Oncology, 30, abstr 4665.
-
(2012)
Journal of Clinical Oncology
, vol.30
-
-
Montgomery, R.B.1
Eisenberger, M.A.2
Rettig, M.3
Chu, F.4
Pili, R.5
Stephenson, J.6
Vogelzang, N.J.7
Morrison, J.8
Taplin, M.9
-
259
-
-
79957443342
-
Abiraterone and increased survival in metastatic prostate cancer
-
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Jr., Saad, F., Staffurth, J. N., Mainwaring, P., Harland, S., Flaig, T. W., Hutson, T. E., Cheng, T., Patterson, H., Hainsworth, J. D., Ryan, C. J., Sternberg, C. N., Ellard, S. L., Flechon, A., Saleh, M., Scholz, M., Efstathiou, E., Zivi, A., Bianchini, D., Loriot, Y., Chieffo, N., Kheoh, T., Haqq, C. M., & Scher, H. I. (2011). Abiraterone and increased survival in metastatic prostate cancer. The New England Journal of Medicine, 364, 1995-2005.
-
(2011)
The New England Journal of Medicine
, vol.364
, pp. 1995-2005
-
-
De Bono, J.S.1
Logothetis, C.J.2
Molina, A.3
Fizazi, K.4
North, S.5
Chu, L.6
Chi, K.N.7
Jones, R.J.8
Goodman Jr., O.B.9
Saad, F.10
Staffurth, J.N.11
Mainwaring, P.12
Harland, S.13
Flaig, T.W.14
Hutson, T.E.15
Cheng, T.16
Patterson, H.17
Hainsworth, J.D.18
Ryan, C.J.19
Sternberg, C.N.20
Ellard, S.L.21
Flechon, A.22
Saleh, M.23
Scholz, M.24
Efstathiou, E.25
Zivi, A.26
Bianchini, D.27
Loriot, Y.28
Chieffo, N.29
Kheoh, T.30
Haqq, C.M.31
Scher, H.I.32
more..
-
260
-
-
84872078210
-
Abiraterone in metastatic prostate cancer without previous chemotherapy
-
Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., Carles, J., Mulders, P. F., Basch, E., Small, E. J., Saad, F., Schrijvers, D., Van Poppel, H., Mukherjee, S. D., Suttmann, H., Gerritsen, W. R., Flaig, T. W., George, D. J., Yu, E. Y., Efstathiou, E., Pantuck, A., Winquist, E., Higano, C. S., Taplin, M. E., Park, Y., Kheoh, T., Griffin, T., Scher, H. I., & Rathkopf, D. E. (2013). Abiraterone in metastatic prostate cancer without previous chemotherapy. The New England Journal of Medicine, 368, 138-148.
-
(2013)
The New England Journal of Medicine
, vol.368
, pp. 138-148
-
-
Ryan, C.J.1
Smith, M.R.2
De Bono, J.S.3
Molina, A.4
Logothetis, C.J.5
De Souza, P.6
Fizazi, K.7
Mainwaring, P.8
Piulats, J.M.9
Ng, S.10
Carles, J.11
Mulders, P.F.12
Basch, E.13
Small, E.J.14
Saad, F.15
Schrijvers, D.16
Van Poppel, H.17
Mukherjee, S.D.18
Suttmann, H.19
Gerritsen, W.R.20
Flaig, T.W.21
George, D.J.22
Yu, E.Y.23
Efstathiou, E.24
Pantuck, A.25
Winquist, E.26
Higano, C.S.27
Taplin, M.E.28
Park, Y.29
Kheoh, T.30
Griffin, T.31
Scher, H.I.32
Rathkopf, D.E.33
more..
-
261
-
-
84856780403
-
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
-
Kaku, T., Hitaka, T., Ojida, A., Matsunaga, N., Adachi, M., Tanaka, T., Hara, T., Yamaoka, M., Kusaka, M., Okuda, T., Asahi, S., Furuya, S., & Tasaka, A. (2011). Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer. Bioorganic & Medicinal Chemistry, 19, 6383-6399.
-
(2011)
Bioorganic & Medicinal Chemistry
, vol.19
, pp. 6383-6399
-
-
Kaku, T.1
Hitaka, T.2
Ojida, A.3
Matsunaga, N.4
Adachi, M.5
Tanaka, T.6
Hara, T.7
Yamaoka, M.8
Kusaka, M.9
Okuda, T.10
Asahi, S.11
Furuya, S.12
Tasaka, A.13
-
262
-
-
84873134086
-
Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumors
-
Yarom, N., Stewart, D., Malik, R., Wells, J., Avruch, L., & Jonker, D. J. (2013). Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumors. Current Clinical Pharmacology, 8, 81-88.
-
(2013)
Current Clinical Pharmacology
, vol.8
, pp. 81-88
-
-
Yarom, N.1
Stewart, D.2
Malik, R.3
Wells, J.4
Avruch, L.5
Jonker, D.J.6
-
263
-
-
84877884856
-
The invasion inhibitor sarasinoside A1 reverses mesenchymal tumor transformation in an e-cadherin-independent manner
-
Austin, P., Freeman, S. A., Gray, C. A., Gold, M. R., Vogl, A. W., Andersen, R. J., Roberge, M., & Roskelley, C. D. (2013). The invasion inhibitor sarasinoside A1 reverses mesenchymal tumor transformation in an e-cadherin-independent manner. Molecular Cancer Research, 11, 530-540.
-
(2013)
Molecular Cancer Research
, vol.11
, pp. 530-540
-
-
Austin, P.1
Freeman, S.A.2
Gray, C.A.3
Gold, M.R.4
Vogl, A.W.5
Andersen, R.J.6
Roberge, M.7
Roskelley, C.D.8
-
264
-
-
84863940282
-
Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression
-
Feng, S., Shao, L., Yu, W., Gavine, P., & Ittmann, M. (2012). Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression. Clinical Cancer Research, 18, 3880-3888.
-
(2012)
Clinical Cancer Research
, vol.18
, pp. 3880-3888
-
-
Feng, S.1
Shao, L.2
Yu, W.3
Gavine, P.4
Ittmann, M.5
|